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 Bioremediation of high concentrations of halomethanes e.g., carbon tetrachloride 
(CT), trichlorofluoromethane (CFC-11) and chloroform (CF) has seldom been addressed 
before and remains highly challenging.  A microcosm study was conducted to investigate 
bioremediation strategies for groundwater contaminated with CT (6 to 10 mg/L), CFC-11 
(1 to 26 mg/L), CF (3-500 mg/L), and 1,1-dichloroethene (1,1-DCE; up to 9 mg/L) at a 
former industrial site in California.  Biostimulation with corn syrup and catalytic amounts 
of vitamin B12 was demonstrated as a feasible remedial strategy and bioaugmentation 
with B12 represents the most promising bioremediation method of the ones studied.  
Halomethane transformation occurred sequentially, i.e., CT was transfo med first, 
followed by CFC-11, then CF. 14C analyses revealed that the dominant end products of 
CT and CF transformation were CO, CO2 and organic acids.  Bioaugmentation with 
enriched indigenous sulfate-reducing cultures grown on lactate or ethanol without prior 
acclimation to halomethanes was effective in enhancing transformati n of CT and CFC-
11, although limitations existed.  In addition, a fermentative enrichment culture appeared 
to be a promising bioaugmentation culture for transforming high concentrations of CF. 
 Bioremediation of high concentrations of CF in groundwater is challenging 
because of its high toxicity and inhibitory effect on most anaerobic prokaryotes.  
Enrichment and field applications of cultures that can transform high concentrations of 
CF (>100 mg/L) are not currently available.    DHM-1, a fermentative enrichment culture 
grown on corn syrup, was developed in this study by using soil samples from the 
California industrial site.  DHM-1 was demonstrated to transform ver 500 mg/L CF in 
 iii  
the presence of catalytic amounts of vitamin B12 at a rate as high as 22 mg/L/d in a 
mineral salts medium. Production of non-toxic end products, i.e., CO, CO2, and organic 
acids indicates hydrolytic reactions as the dominating pathway.  DHM-1 is facultative 
and can grow on corn syrup while transforming high concentrations of CF, which makes 
it a promising culture for bioaugmentation.  The two strains isolated from DHM-1 are 
related to Pantoea spp., and both possess equal or even slightly better CF transforming 
capability than the DHM-1 enrichment.  Development of DHM-1 and isolation of the two 
Pantoea spp. makes bioremediation of source zone CF contamination possible for the 
first time. 
 Following the development and characterization of DHM-1, the capacity of 
DHM-1 for biotransformation of high concentrations of halogenated methan s was 
explored.  With the addition of catalytic amounts of vitamin B12, DHM-1 can readily 
transform at least 2000 mg/L CF, which is equal to one fourth of t e CF solubility in 
water.  In addition, DHM-1 is able to transform CT and CFC-11 as well. Complete 
transformation of a mixture of 11 mg/L CT, 24 mg/L CFC-11 and 500 mg/L CF was 
achieved in less than four months by DHM-1 in a mineral salts medium. This study also 
demonstrated the capability of SDC-9, a commercially available mixed culture, to 
transform high concentrations of halomethanes.  DHM-1 has an advantage over SDC-9 in 
terms of the rate of CF transformation, while SDC-9 exhibited b tter kinetics with CFC-
11.  A second microcosm study with soil and water from the California industrial site 
further demonstrated the use of these two cultures for bioaugmentation to enhance in situ 
bioremediation of groundwater contaminated by high concentrations of halomethanes. 
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 This study for the first time makes source zone bioremediation of hal methanes 
contamination possible.  DHM-1 and the two isolates (patent pending) develop d in this 
study are the first mixed and pure cultures, respectively, reported to biotransform high 
concentrations of CF and other halomethanes to non-toxic end products.  DHM-1 is a 
promising bioaugmentation culture for in situ bioremediation of high concentrations of 
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1. INTRODUCTION AND OBJECTIVES 
 In spite of major recent advances in bioremediation of contaminated groundwater, 
significant challenges remain.  One of these challenges involves developing effective 
methods to bioremediate halogenated methanes, including carbon tetrachloride (CT), 
chloroform (CF), and trichlorofluoromethane (CFC-11).  Although halogenated methanes 
receive less attention than chlorinated ethenes, they are among the most significant 
groundwater contaminants.  The Superfund Act requires preparation of a list each year of 
substances found at facilities on the National Priority List that pose the most significant 
potential threat to human health.  In the 2007 Priority List of Hazardous Substances of th   
Environmental Protection Agency, CF ranks the third highest among chlorinated organics, 
after vinyl chloride and polychlorinated biphenyls (8).  This is a reflection of how 
frequently CF is detected in groundwater and its high level of toxici y.  Although not 
ranked as highly, CT is also on the list, and CFC-11 is often a co-contaminant with CT 
and CF.  CT had a long history of use as an industrial solvent and as a ry-cleaning agent 
before it was banned in 1970 in consumer products in the U.S., followed by a complete 
ban in 1996 according to the Montreal Protocol. Improper disposal, spills and eaks from 
underground storage tanks have resulted in widespread contamination of groundwater. 
CFC-11, also known as Freon®-11, has been extensively used as a foam-blowing agent, 
an aerosol propellant and a refrigerant. Its well-known adverse environmental impacts 
include ozone layer depletion (5) and contribution to global warming (29).  
All of these contaminants can be transformed by subsurface anaerobic 
microorganisms to nonhazardous products, although some of the pathways involved for 
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halogenated methanes are considerably different from the reductive dechlorination 
process that predominates with chlorinated ethenes.  Among these compounds, CF is the 
focal point for evaluating the feasibility of bioremediation, since it is very toxic to most 
obligate anaerobic prokaryotes. For example, only 1 mg/L of CF completely inhibited 
tetrachloroethene dechlorination by a mixed chlororespiring anaerobic culture (73). 
Inhibition of reductive dechlorination of chloroethenes by CF is a general problem for 
sites co-contaminated with CF, and can only be overcome by removing the CF first (73).  
In other words, until a substantial decrease in CF is achieved, little biological activity is 
likely to occur on the other contaminants.  Inhibitory effects of CT (20) and CFC-11 (57) 
on anaerobes at low concentrations have been reported as well.  
  At this point in time, it appears that anaerobic biotransformation of CT, CF and 
CFC-11 is strictly a cometabolic process.  No cultures have been shown capable of using 
these compounds as growth-linked substrates.  Use of CT and CF as terminal electron 
acceptors is theoretically possible, as has been demonstrated with chlorinated ethenes via 
chlororespiration (49, 72).  Use of dichloromethane (DCM) as a sole carbon and energy 
source (i.e., electron donor) under fermentative conditions is well established (14).  
Although this is theoretically possible with CF, it has not been shown (12) and is unlikely 
due to the much higher toxicity of CF compared to DCM.  Therefore, bioremediation of 
CT, CFC-11 and CF is more challenging than that of chloroethenes and DCM because 
cometabolic transformations are more difficult to engineer than metabolic pr cesses. 
 Aerobic transformation of CT and CFC-11 is unfavorable because of their fully 
oxidized carbons. Although aerobic biotransformation of CF is possible (e.g., 
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cometabolism by a butane-grown strain (30)), CF is more difficult to cometabolize than 
trichloroethene (88), in part due to its more toxic transformation intermediate (i.e., 
phosgene versus TCE-epoxide). Thus, most studies on biotransformation and 
bioremediation of these halomethanes are limited to anaerobic conditions. 
 The most economical bioremediation strategy is monitored natural attenuation 
(MNA). A premise of MNA is the presence of high background levels of organic 
compounds, i.e., electron donors, either within the contaminant plume or the aquif r 
through which the plume passes. Moreover, MNA usually would not be an option for 
highly contaminated sites because it could take an unreasonably long period of time to 
clean them up. It is, therefore, unrealistic to rely on MNA to remediate any plumes 
contaminated with high concentrations of halomethanes. More aggressive strategies are 
needed. 
 The only way known to date to enhance anaerobic biotransformation of tetra- and 
trihalomethanes is by biostimulation.  Many organic substrates have pro n effective at 
biostimulating CT and CF transformation, including alcohols (e.g., methanol (9)), sugars 
(e.g., fructose (47)) and organic acids (e.g., acetate (24, 36)).  Hydrogen is also effective, 
although it is not considered a “universal donor” for CT and CF dechlorinati n the way it 
is for chlorinated ethenes. One of the objectives of this dissertation was to compare the 
effectiveness of several electron donors for anaerobic transformation of halomethanes.  
 Corrinoids such as cyanocobalamin (i.e., vitamin B12) are effective catalysts (even 
at micromolar concentrations) for increasing the rate of CT and CF biotransformation. 
The effect of B12 on accelerating transformation of CFC-11, however, has not yet been 
 4
investigated. Addition of cyanocobalamin also shifts the pathway awa from reductive 
dechlorination and towards formation of environmentally benign products such as CO, 
CO2 and organic acids (12, 47, 48).  Although the high unit cost of cyanocobalamin is a 
concern, its effectiveness has been demonstrated at the field scale with in situ 
dechlorination of CT and 1,1,1,2-tetrachloroethane.  Cyanocobalamin was added with 
titanium citrate and glucose in a recirculating well at Aberdeen Proving Grounds, MD, 
with promising results (63).  Delivery of cyanocobalamin along with an electron donor is 
likely to be technically feasible because it is highly soluble and does not adsorb 
significantly to most aquifer solids (46).  
 The potential for using bioremediation to remediate groundwater contaminated 
with high concentrations of halomethanes is being considered for an industr al site in 
California. This site  represents a complicated contamination scenario, with halomethanes 
at concentrations ranging from 6-10 mg/L of CT, 1-26 mg/L of CFC-11, and 3-500 mg/L 
of CF, and up to 9 mg/L 1,1-dichloroethene.   Current groundwater conditions are highly 
unfavorable to bioremediation, including pH levels as low as 3, total halomethanes 
concentrations above 500 mg/L, and positive Eh levels.  Because these conditions have 
existed for several decades, it seems likely that the population of indigenous 
microorganisms is quite low and, therefore, bioaugmentation may be required, although 
bioaugmentation cultures have not been evaluated for this purpose.  One of the objectives 
of this dissertation was to develop a bioaugmentation culture that may be used for 
treating high concentrations of halomethanes. 
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 The highest concentrations listed above for the California site suggest the 
presence of dense nonaqueous phase liquids, based on aqueous phase concentrations that 
exceed one percent of water saturation (i.e., approximately 800 mg/L for CT; 8000 mg/L 
for CF, and 1100 mg/L for CFC-11).  At concentrations this high, it may seem 
impractical to consider bioremediation, due to the inherent toxicity of these lipophilic 
compounds.  However, a growing body of evidence indicates that bioremediation at 
concentrations approaching those found near source zones (i.e., close to water saturation) 
is feasible with chlorinated ethenes (51).  Indeed, reductive dechlorination of the 
chlorinated ethenes enhances dissolution of the nonaqueous phase.  It is not yet k wn if 
microbes capable of transforming halomethanes can also function a  such high 
concentrations.  A key difference is the fact that chlorinated ethen s are typically used as 
growth-linked terminal electron acceptors during chlororespiration, while transformation 
of CT, CFC-11 and CF is cometabolic.  This means there may be less “incentive” for the 
microbes to transform the contaminants at the high concentrations found near source 
zones.  One of the objectives of this dissertation was to evaluate the tolerance of an 
enrichment culture that transforms CF to concentrations as high as 50% of water 
saturation.   
  Among the tetrahalo- and trihalomethanes, CT appears to undergo 
biotransformation most readily. Acetobacterium woodii (47) and sulfate reducing 
enrichment cultures developed by Freedman et al. (36) (using anaerobic digester sludge 
from a municipal wastewater treatment plant as inoculum) can transform 92 and 350 
mg/L CT in the presence of catalytic amounts of hydroxocobalamin or cyanocobalamin, 
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respectively. Nonetheless, transformation of CT by Acetobacterium woodii was tested at 
35°C and no studies were found that evaluated the ability of A. woodii to transform CF.  
The sulfate reducing culture is not suitable for in situ application because the main 
product formed was carbon disulfide (CS2) (73%); although CS2 is not regulated as a 
drinking water contaminant, it is a potent neurotoxin and is, therefore, an undesirable 
transformation product. Few studies have investigated anaerobic biotransf rmation of 
CFC-11 or CF close to the very high concentrations reported at the California industrial 
site mentioned above. Becker and Freedman (12) were able to biotransf rm up to 260 
mg/L of CF in an enrichment culture (grown on DCM as the sole substrate) when vitamin 
B12 was also added.  Under these conditions, less than 1% of the CF accumulated as 
DCM, chloromethane, or methane.  Corresponding experiments with [14C]CF identified 
the main product as 14CO2, followed by 
14CO and soluble products (presumptively 
organic acids).  However, use of this culture is not practical for in situ bioremediation, 
since it requires DCM as a growth substrate and only grows well at 35oC.  The above-
mentioned sulfate reducing culture can also transform up to 270 mg/L CF, although the 
predominant product is DCM, which is not an acceptable endpoint (36). The higst 
concentration of CFC-11 evaluated in previous biotransformation studies is 2.2 mg/L, an 
order of magnitude lower than the highest concentration found at the industr al site 
mentioned above.  At low concentrations, Methanosarcina barkeri transformed CFC-11 
via reductive dechlorination to dichlorofluoromethane (HCFC-21) (66%) as the dominant 
end product (57).  Halogenated methanes are not acceptable endpoints for successful 
bioremediation.   
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 A summary of the biotic and non-enzymatic pathways involved in transformation 
of CT, CF and CFC-11 under low redox anaerobic conditions (i.e., Eh < -100 mV) is 
shown in Figure 1-1.  Reductive dechlorination of CT to CF is often a significant 
pathway, but unlike the chlorinated ethenes, reductive dechlorination of CFmay not be 
the dominant pathway.  Depending on environmental conditions, net hydrolysis f CF to 
CO can be extensive, with subsequent oxidation of CO to CO2 and use of the resulting 
equivalents to form organic acids.  Likewise, CT can undergo reductive hydrolysis t CO.  
In the presence of sulfide and a coenzyme, e.g., vitamin B12, or surface catalysts, e.g., 
biotite (56) and pyrite (55), significant conversion of CT to CS2 is also possible.  Abiotic 
transformation of CS2 to CO2 is possible under alkaline conditions.  
  Reductive dechlorination of CF to DCM is also an important pathway, but it 
rarely occurs stoichiometrically.  Furthermore, reductive dechlorination of DCM to 
chloromethane is a minor pathway, and methane is a trivial overall reductive 
dechlorination product.  Instead, under low redox conditions, DCM may undergo 
fermentation (as a sole source of carbon and energy) to acetate and formate.  Formate can 
subsequently be fermented to CO2 + H2 and other organic acids (14, 33, 34, 70-72).   
 The pathways shown in Figure 1-1 indicate that completing a mass balance for the 
daughter products from CT and CF is more complicated that simply monitoring 
halogenated methanes.  A complete mass balance is feasible only under controlled 
conditions, such as in a laboratory microcosm study, using 14C-labeled parent compounds. 
[14C]CT and [14C]CF are commercially available at a reasonable cost while [14C]CFC-11 
is available only by custom synthesis, making its use prohibitively expensive for typical 
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microcosm studies.  Using 14C-labeled parent compounds makes it possible to monitor 
products such as 14CO, 14CO2, 
14C-labeled organic acids, and 14C assimilated into 
biomass.  Each of these products can be formed by fermentation and anaerobic 
respiration of nonhalogenated substrates, so the use of 14C-labeled parent compounds is 
essential to delineate their origin.   
 CFC-11 undergoes similar transformations to CT.  However, since de hlorination 
is more thermodynamically favorable than defluorination, HCFC-21 and 
chlorofluoromethane (HCFC-31) tend to accumulate.  As with CT, reductive hydrolysis 
of CFC-11 to CO is well documented (58), as shown in Figure 1-1.  Net hydrolysis of 
HCFC-21 to CO is also possible.  While fermentation of DCM to organic acids is well 
established, it is not yet known if the same types of microbes (e.g., Dehalobacterium 
formicoaceticum) can also use chlorofluoromethane as a substrate (hence the question 
mark on Figure 1.1 for this transformation). 
 The overall objective of this dissertation was to develop improved strategies for in 
situ bioremediation of high concentrations of halomethanes that occur as co-contaminants 
with chlorinated ethenes.  A key component of this approach was the development of an 
enrichment culture for use in bioaugmentation.  The specific objectives were:   
1. To determine if in-situ biostimulation with substrates such as corn syrup, lactate 
and emulsified vegetable oil can stimulate the growth of microbes that transform 
halomethanes and evaluate the microbial community response to biostimulation. 
This objective is addressed in Chapter 2.  
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2. To determine if adding catalytic amounts of vitamin B12 along with an electron 
donor can significantly enhance the rate of halomethane transformatin nd 
minimize the accumulation of halogenated daughter products. This objective is 
addressed in Chapter 2.   
3. To determine if bioaugmentation with sulfate-reducing or fermentative 
enrichment cultures (developed using indigenous microbes from the contamina ed 
industrial site in California) with vitamin B12 addition can result in a faster rate of 
biotransformation without accumulation of toxic daughter products. This 
objective is addressed in Chapter 2.    
4. To develop and characterize an enrichment culture that is relevant to use in 
bioaugmentation, including its ability to transform CF at concentrations as high as 
50% of water saturation. This objective is addressed in Chapters 3 and 4.  
5. To isolate and characterize the microbes that are responsible for CF 
transformation from the enrichment culture. This objective is addressed in 
Chapter 3.  
6. To determine the capacity of the enrichment culture for transforming high 
concentrations of halomethanes. This objective is addressed in Chapter 4.  
7. To compare the enrichment culture developed during this research with a 
commercially available culture in terms of their ability to transform high 
concentrations of halomethanes, in both defined media and in microcosms. This 
objective is addressed in Chapter 4. 
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 Chapters 2, 3 and 4 are “stand-alone”, i.e., each presents an introduction, 
materials and methods, results and discussion section that fully address on  or several of 
the specific objectives. Chapter 5 provides a comprehensive list of conclusions for this 













Figure 1-1 Pathways for biotransformation of CT, CF, and CFC-11 under low redox 
conditions.  Further reduction of DCM to chloromethane and methane is possible, 
but occurs at very slow rates.  Numbers in parentheses represent oxidation states of 
the carbon, with the exception of organic acids; i.e., not all of these have carbon with 
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2. EVALUATION OF STRATEGIES FOR ANAEROBIC BIOREMEDIATION OF 
HIGH CONCENTRATIONS OF HALOMETHANES 
2.1 Abstract 
 Bioremediation of high concentrations of halomethanes e.g., >10 mg/L of 
trichlorofluoromethane (CFC-11) or >100 mg/L chloroform (CF) has verys ldom been 
addressed before and remains highly challenging. This microcosm study i  the first to 
investigate bioremediation strategies to clean up groundwater contaminated with carbon 
tetrachloride (CT) up to 10 mg/L, CFC-11 up to 26 mg/L, CF up to 500 mg/L, and  1,1-
dichloroethene (1,1-DCE; up to 9 mg/L). Biostimulation with corn syrup and catalytic 
amounts of vitamin B12 appeared to be a practical remedial method, while 
bioaugmentation with B12 proved the most promising bioremediation strategy. 
Halomethane transformation occurred sequentially, i.e., CT, then CFC-11, then CF. 14C 
analyses revealed that the dominant end products of CT and CF transformation are CO, 
CO2 and organic acids. Bioaugmentation with enriched indigenous sulfate-reducing 
bacteria (SRB) grown on lactate and ethanol without prior acclimation to halomethanes 
were effective in enhancing transformation of CT and CFC-11, although limitations 
existed. A fermentative enrichment culture acclimated to 500 mg/L of CF appeared to be 
a promising bioaugmentation culture for treatment of this toxic halomethane.  
2.2 Introduction 
 In spite of recent advances in bioremediation of contaminated groundwater, 
significant challenges remain.  One of these involves developing effective methods to 
bioremediate halogenated methanes, including CT, CF, and CFC-11.  In the 2007 
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CERCLA Priority List of Hazardous Substances, CF ranks number 11, the third highest 
among chlorinated organics, after vinyl chloride (VC) and polychlorinated biphenyls.  
This is a reflection of how frequently CF is detected in groundwater and its high level of 
toxicity.  Although not ranked as highly, CT is also on the list, and CFC-11 is often a co-
contaminant with CT and CF (8).   
 All of these contaminants can be transformed by subsurface anaerobic 
microorganisms to nonhazardous products, although some of the pathways involved for 
halogenated methanes are considerably different from the reductive dechlorination 
process that predominates with chlorinated ethenes.  Among these compounds, CF is 
often the focal point for evaluating the feasibility of bioremediation, since it is very toxic 
to most obligate anaerobic prokaryotes. For example, only 1 mg/L of CF completely 
inhibited reductive dechlorination of tetrachloroethene (73). Inhibition of reductive 
dechlorination of chloroethenes by CF is a general problem for sites co-contaminated 
with CF, and can only be overcome by removing the CF first (73).  Inhibitory effects of 
CT (20) and CFC-11 (57) on anaerobes at low concentrations have been reported as well.  
 Aerobic transformation of CT and CFC-11 is unfavorable because of their fully 
oxidized carbons. Although aerobic biotransformation of CF is possible (e.g., 
cometabolism by a butane-grown strain (30)), CF is even moredifficult to cometabolize 
than trichloroethene (88). Thus, most studies on biotransformation and bioremediation of 
these halomethanes are limited to anaerobic conditions. Anaerobic biotransf rmation of 
CT, CF and CFC-11 appears to be achievable only by cometabolic processes.  
Cometabolic transformation of high concentrations of nongrowth compounds is 
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especially challenging.  The highest concentrations demonstrated with biotransformation 
are 270 mg/L for CF using a dichloromethane (DCM)-grown culture (12)or lactate-
grown sulfate-reducing culture (36); 350 mg/L for CT using a lactate-grown sulfate-
reducing enrichment culture (36); and 2.2 mg/L for CFC-11 by Methanosarcina barkeri 
(57).  The cultures used with CT and CF are not generally applicable to groundwater 
remediation (i.e., DCM was used as the growth substrate at 35°C) or the products formed 
are not acceptable (i.e., CS2 from CT or DCM from CF with the sulfate-reducing 
enrichment).  Although studies have demonstrated that in si u biotransformation of CT 
via bioaugmentation is achievable, the concentrations evaluated were considerably lower, 
e.g., less than 5 mg/L (23, 24).  Methods to achieve n situ biotransformation of high 
concentrations of halomethanes to nonhazardous products have not yet been reported.   
 Addition of electron donor (i.e., biostimulation) is the only way known to enhance 
anaerobic biotransformation of tetra- and trihalomethanes.  Many organic substrates have 
proven effective for this purpose, including alcohols (e.g., methanol) (9), sugars (e.g., 
fructose) (47) and organic acids (e.g., acetate) (36).  Hydrogen is also effective, although 
it is not considered a “universal donor” for halomethanes the way it is for chlorinated 
ethenes.  In addition to providing electron donors, addition of corrinoids such as 
cyanocobalamin (i.e., vitamin B12) has been shown to be advantageous.  Catalytic levels 
of B12 increase the rate of halomethane biotransformation and shift the pat way away 
from reductive dechlorination and towards hydrolytic and substitutive reactions forming 
CO, CO2, and organic acids (12, 47, 48).  The importance of B12 for chlororespiration of 
chlorinated ethenes is well established (4) and B12 is increasingly being included in 
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electron donor formulations used for in situ bioremediation (e.g., 
http://eosremediation.com/).  Addition of B12 has also been used to enhance in situ abiotic 
transformation of CT (63).   
 The potential for bioremediation of groundwater contaminated with halomethanes 
is being considered for an industrial site in California.  Concentrations range from 6-10 
mg/L of CT, 1-26 mg/L of CFC-11, and 3-500 mg/L of CF.  1,1-Dichloroethene (DCE) is 
also present (10 mg/L), presumably from dehydrohalogenation of 1,1,1-trichloroethane.  
Geochemical conditions are unfavorable to anaerobic bioremediation (e.g., acidic pH, 
high halomethanes concentrations, and positive Eh levels) and have existed for decades.  
The overall objective of this research was to develop a bioremediation s rategy for 
remediation of high concentrations of halomethanes. This entailed evaluating several 
electron donors; testing the effectiveness of B12 to enhance biotransformation; and 
evaluating several enrichment cultures for their use in bioaugmentation.  The results 
revealed that corn syrup was the most effective of the substrates tes d, catalytic levels of 
B12 significantly enhanced the rates of halomethane transformation, biaugmentation 
further enhanced the rates of transformation, and removal of halomethanes enabled 
subsequent reductive dechlorination of 1,1-DCE.    
2.3 Materials and methods 
2.3.1 Chemicals and radioisotopes  
 CT (99.9%, Sigma-Aldrich), CF (99.7%, Shelton Scientific), DCM (99.9%, 
AlliedSignal), CFC-11 (99%, Aldrich), 1,1-DCE (99%, TCI America), and CS2 (100%, 
J.T.Baker) were obtained as neat liquids.  Chloromethane (CM; 99%, Praxair), 
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dichlorofluoromethane (HCFC-21) (99%, SynQuest Labs), chlorofluoromethane (HCFC-
31) (99%, SynQuest Labs), VC (99.9%, Matheson), and methane (99.99%, Matheson) 
were obtained as neat gases.  Sodium lactate (60% syrup, EM Science), corn syrup 
(regular type, Sweetener Products Company), and emulsified vegetable oil (standard type, 
Newman Zone), were used as electron donors.  The chemical oxygen demand (COD) for 
corn syrup and emulsified vegetable oil was calculated based on their presumed 
composition, i.e., C6H12O6 and C8H16O, respectively.   Cyanocobalamin (i.e., vitamin B12, 
USP grade) was obtained from Research Organics, Inc.  All otherreagents were ACS 
grade or higher.  Neat 14C-labeled CT (1.0 mCi/mmol) and CF (0.5 mCi/mmol) were 
purchased from American Radiolabeled Chemicals, Inc.  Stock solutions were prepared 
in deionized distilled water with approximately 107 disintegrations per minute (dpm) per 
mL.   
2.3.2 Soil and groundwater 
 Soil and groundwater samples were obtained from three areas of the plumes at the 
former industrial site in California, corresponding to high, medium and low
concentrations of halomethanes.  Core samples of soil from the saturated zone were 
delivered in stainless steel sleeves (6 cm in diameter by 46 cm long) from 23-32 m below 
grade.  Groundwater samples were obtained from monitoring wells closest to the core 
samples.  Groundwater from the low and medium concentration areas had pH levels of 
3.3-3.5 (Table 2-1).  Anticipating that this would not be favorable to biostimulation or 
bioaugmentation, the pH was adjusted to near neutral using sodium carbonate.  Notable 
amounts of an orange/brown precipitate formed (Table 2-1).  This was consistent with the 
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high level of calcium (1300-2000 ppm), aluminum (210-470 ppm) and iron (87-170 ppm) 
in the soils.  Soil organic matter was below 0.2%, indicating a low background level of 
electron donor needed for biotransformation of the halogenated contaminants.  Nitrate in 
the groundwater was below detection (1 mg/L); sulfate levels were approximately 3800, 
2800 and 420 mg/L in the groundwater with low, medium and high concentrations of 
halomethanes.   
2.3.3 Microcosms 
 Eight types of treatments were evaluated (all were pH-adjusted):  live with no 
electron donor added (i.e., as-is); biostimulation with lactate; biostimulation with 
emulsified vegetable oil; biostimulation with corn syrup; biostimulation with corn syrup 
+ B12; bioaugmentation (which also includes addition of lactate, ethanol, corn syrup and 
B12); autoclaved controls (AC); and water controls (WC).  Each treatm nt at each 
concentration range (Table 2-2) included two sets of triplicate microcosms; one set was 
prepared with [14C]CF and another set with [14C]CT, thereby permitting an evaluation of 
the fate of each compound based on 14C.   
  Microcosms were prepared in 160 mL serum bottles with 20 g of soil and 50 mL 
of liquid (46.8-48.4 mL of pH-adjusted groundwater from the appropriate locations + 1.6-
3.2 mL of the halogenated compounds), in an anaerobic chamber (Coy Laboratories) 
containing an atmosphere of approximately 98% N2 and 2% H2, and sealed with 20-mm 
Teflon-faced red rubber septa and aluminum crimp caps.  The precipitate that formed in 
the groundwater due to pH adjustment was not separated from the groundwater, as would 
occur if the pH was adjusted in situ.  Resazurin was added to the groundwater (1 mg/L) to 
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serve as a redox indicator.  The volume of 20 g of soil was determin d by volumetric 
displacement to be 11 mL.  Consequently, the gas volume in the microcosms was 
approximately 99 mL.  AC bottles contained soil and pH-adjusted groundwater and were 
autoclaved for 1 h on three consecutive days; halogenated compounds were added after 
autoclaving.  WC bottles received only distilled deionized water (50 mL) and the 
halogenated compounds.    
 Analyses of groundwater as received from each plume location indicate  that the 
concentrations of the halomethanes and 1,1-DCE in were below the target levels, which 
were based on the highest concentration of contaminants reported.  To achieve the target 
initial concentrations (Table 2-2), water saturated solutions were used (1.6-3.2 mL/bottle) 
except for CF and CFC-11 in the high concentration bottles; in this case, neat compounds 
were added (5 µL CFC-11, 18 µL CF).  Due to the high vapor pressure of CFC-11, it was 
necessary to cool the syringe and the neat compound to 4ºC prior to adding it to the 
microcosms.    
 The initial amount of electron donor provided was 500 mg/L as COD.  
Subsequent additions of electron donors (250-500 mg COD/L per dose) were made at 
approximately 2-3 month intervals for the biostimulation microcosms, while more 
frequent additions were applied to bioaugmentation microcosms, especially after adding 
the cultures. [14C]CT and [14C]CF were added using stock solutions such that the initial 
level of activity was approximately 1.3 x 106 dpm per bottle.  Subsequently, the 
microcosms were placed on a shaker table for approximately 15 min, incubated 
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quiescently overnight, and then analyzed for the initial total amount f dpm and volatile 
organic compounds.  
 The pH of the microcosms was tested approximately once per month usi g 20 µL 
samples and pH strips.  When the pH dropped below 6.5, 8M NaOH was added to raise 
the pH to 7.0-7.7.  When the microcosms were not being sampled, they wer  stored in an 
inverted position in boxes quiescently at room temperature in the anaerobic chamber.  
 First order transformation rates for each halomethane were calculated using data 
following the lag phase prior to the onset of transformation, i.e., the period of time when 
there was no significant decrease in the amounts per bottle.  Data from triplicate bottles 
were pooled and fit with a logarithmic curve to determine the first order rate for each 
compound and treatment in each concentration range.   
2.3.4 Analysis of volatile organic compounds 
 Halogenated (CT, CF, DCM, CM, CFC-11, HCFC-21, HCFC-31) and 
nonhalogenated volatile compounds (methane, ethane, ethene, CS2) were monitored by 
gas chromatographic analysis of 0.5 mL headspace samples, as previously described (35). 
A Hewlett Packard 5890 Series II gas chromatograph (GC) equipped with a flame 
ionization detector and a 2.44 m × 3.175 mm column packed with 1% SP-1000 on 60/80 
Carbopack B (Supelco) was used.  A GC response factor for each volatile rganic 
compound was measured to relate the total mass of the compound to the GC peak area 
(38).  Results are reported in terms of the µmoles per bottle, in order to easily reveal the 
stoichiometry of the transformations.  In the text, aqueous phase conc ntrations are also 
reported, based on partitioning of the compounds between the headspace and aqueous 
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phases (47).  Previously reported values for Henry’s Law constants (Hc) at 23°C were 
used (7, 38).  The detection limit of this method is lower than the maximum contaminant 
level (MCL) for each of the chlorinated compounds.  
2.3.5 Analysis of 14C-labeled compounds 
 The initial total amount of 14C activity present was determined by counting a 
sample of the headspace (0.5 mL) and liquid (0.1 mL) in 10 mL liquid scintillation 
cocktail (LSC).  At the point when a bottle was ready to be sacrificed for analysis of the 
14C distribution, the amount of 14C activity remaining was determined after raising the pH 
of the liquid phase (0.75 mL 10 M NaOH) in order to drive CO2 in the headspace into the 
liquid phase.  14C activity remaining was determined by counting a headspace sample 
(0.5 mL) and slurry sample (1 mL), to account for any 14C activity that may have 
partitioned to the soil.  A WALLAC 1415 liquid scintillation counter was u ed to 
quantify 14C activity.  Corrections for counting efficiency were made according to a 
quench curve (sample spectral Quench Parameter-Eternal (i.e., SQP(E)) versus efficiency) 
after incubating them overnight in the dark.   
 Volatile 14C-labeled compounds (primarily CT, CF, DCM, CO, and CS2) were 
analyzed with a GC-combustion technique, as previously described (35). A 0 5-mL 
headspace sample from the microcosms (prior to adding NaOH) was injected onto the 
Carbopack B column and the well-separated compounds were routed to a catalytic 
combustion tube (containing CuO), where the compounds were oxidized at 800°C to CO2.  
Each fraction was then trapped in 3 mL of 0.5 M NaOH and added to 15 mL LSC.  
Whenever 14C activity exceeded 200 dpm in the first fraction (0-1.1 min), which was 
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associated with the poorly-separated methane, CO and CO2, a second headspace sample 
was injected onto a Carbosieve SII column (2.44-m by 3.175-mm; Supelco), which 
efficiently separates the one carbon gases.  Fractions eluting from the Carbosieve column 
were used to determine 14CO and 14CH4.  
14CO2 was determined during analysis of 
14C in 
the liquid phase (see below).  The efficiency of the combustion technique (Σ14C in the 
fractions divided by the 14C in a headspace sample) averaged 123±30% for the 
Carbopack column and 106±20% for the Carbosieve column.  Apparently higher 
recoveries occurred when CO was a major product because of the poor dissolution of CO 
in LSC (thereby underestimating the total activity present in the direct sample).  The 
procedure used to convert the 14C activity in each fraction to total 14C activity for each 
volatile compound in a microcosm required the use of Henry’s Law constants, as 
previously described (19, 35).   
 The 14C liquid analyses were done using a modified version of a previously 
described protocol (33). At the end of the incubation period and after adding NaOHto the 
microcosms, a 10 mL sample of well-mixed slurry was transferred to a 25 mL glass test 
tube (“stripping chamber”), which was connected by latex tubing to another 25 mL glass 
test tube (“trapping chamber”) containing 10 mL of 0.5 M NaOH.  To initiate the analysis, 
N2 was bubbled through the stripping chamber and into the trapping chamber.  Th  
contents of the stripping chamber were acidified by adding 0.25 mL of 6 M HCl, 
lowering the pH to below 4.   
 14C activity in the trapping chamber corresponded to 14CO2. This was confirmed 
by precipitation of the 14CO2 with barium hydroxide (35).  
14C activity left in the 
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stripping chamber was referred to as nonstrippable residue (NSR), corresponding to 
products of [14C]CT and [14C]CF that were not purged at acidic pH. The total NSR was 
separated into soluble (sNSR) and particulate (pNSR) fractions by centrifugation (26,600 
g for 10 min; SORVALL® Evolution™ RC superspeed centrifuge).  If sNSR represented 
more than 10% of the total initial 14C activity, its composition was evaluated by injecting 
filtered samples (200 µL) onto a WATERS high performance liquid chromatograph 
(HPLC) using 0.01 N H2SO4 as the eluant and an Aminex® HPX-87H column (300 mm 
x 7.8 mm) for separation of organic acids.  As fractions eluted they were collected in 10 
mL of LSC.  Identification of organic acids was confirmed based on matching of their 
retention times with the retention time of authentic material.  The recovery of sNSR 
through HPLC fractionation (i.e., total dpm in the fractions divided by dpm injected) was 
74±8.4%. 
 The percentage of 14C attributable to each compound or category of compounds, 
the physical losses, and the amount of 14C in the “unaccounted for” category was 
calculated as described elsewhere (19). 
2.3.6 Development of enrichment cultures  
 Given the high concentration of sulfate in the groundwater and the potential for 
SRB to cometabolize halomethanes (36), two SRB enrichment cultures we  developed. 
A fermentative culture was later developed with the intent of further enhancing 
biotransformation. A previously described (32) mineral salts medium (MSM) was used, 
with the following modifications: NaCl and KH2PO4 were excluded; the concentration of 
K2HPO4 and NaHCO3 was changed to 0.41 g/L and 4.0 g/L, respectively; and the 
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headspace consisted of 30% CO2 and 70% N2 instead of helium, resulting a pH of 
approximately 7.5. The bottles were prepared in an anaerobic chamber containing an 
atmosphere of approximately 98% N2 and 2% H2.   
The lactate-grown SRB enrichment was started in a 250 mL glass bottle 
containing 200 mL of MSM, 37.1 mM sulfate, 3 mM sodium lactate and 20 g of soil from 
an uncontaminated area of the same industrial site described above.  Growth was 
monitored based on consumption of sulfate and lactate.  When the lactatewas consumed, 
more was added.  The maximum dose of lactate was kept at 5 mM in order to avoid 
enriching for a fermentation culture that converts lactate to propionate plus acetate (39) 
rather than an SRB culture.  Once a consistent level of lactate and sulfate consumption 
was demonstrated, the enrichment was transferred (1% v/v) to MSM.  After consuming 
approximately 30 mM lactate without significant propionate formation, the protein 
concentration exceeded 100 mg/L and the culture was considered ready for use in 
bioaugmentation. 
A second SRB enrichment culture was developed using ethanol as the carbon and 
energy source to enhance the development of sulfate-reducing conditions because ethanol 
was not fermentable.  Using the lactate enrichment as inoculum, a transfer was made to 
MSM (1% v/v) containing 3 mM ethanol and 1.5 mM ferrous sulfate (to precipitate 
sulfides and minimize the opportunity for sulfide inhibition).  Consumption of ethanol 
was followed indirectly based on accumulation of acetate.  Repeated additions of 3-6 mM 
ethanol were made and sulfate reducing conditions were confirmed based on the 
consumption of sulfate.  After consuming a total of 30-40 mM ethanol, the protein 
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concentration exceeded 100 mg/L and the enrichment culture was considered ready for 
use in bioaugmentation. 
A fermentative enrichment culture was started by combining soil (20 g) from an 
uncontaminated area of the industrial site as inoculum, MSM (100 mL) and corn syrup 
(approximately 7680 mg COD/L) as the primary substrate in 160 mL serum bottles.  
After 1-2 weeks of incubation, the protein level reached 200 µg/mL and a 1% transfer 
was made to MSM and corn syrup.  When the protein concentration reached 200 µg/mL, 
the culture was concentrated by centrifugation (5500 g) and resuspended in MSM (200 
mL) plus corn syrup in a 250 mL bottle sealed with a Teflon-lined rubber septum and 
screw cap.  Acclimation to CF began by adding 2.8 µmol per bottle.  Taking into account 
partitioning to the headspace (see above), the aqueous phase concentration was 1.5 mg/L.  
The initial dose of B12 was 10 µM.  As CF was transformed, increasing amounts of CF 
were added until a final dose of 500 mg/L. Additional B12 was provided to maintain a 
molar ratio of B12 to cumulative CF at 3%. Further additions of corn syrup were based on 
pH, i.e., a decrease in pH indicated that fermentation was occurring due to accumulation 
of organic acids (predominantly formic, acetic and propionic).  When the pH decreas d to 
6.7-7.0, it was raised to 7.5-7.7 with 8 M NaOH.  When the pH stopped decreasing, 
suggesting a cessation in fermentation, more corn syrup was added (approximately 960 
mg COD/L per dose).   
Prior to adding the SRB enrichments to the microcosms, they were concentrated 
100 fold by centrifugation.  Adding 0.5 mL of the concentrate provided the microcosms 
with the same concentration of cells that were in the enrichment cultures.  The 
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fermentative enrichment culture was concentrated 10 fold by centrifugation and 0.2 mL 
of the concentrate was added per dose.     
 Several of the microcosms were bioaugmented with a chloroethene respiring 
enrichment culture for the purpose of enhancing reductive dechlorination of 1,1-DCE.  
This culture was originally enriched on tetrachloroethene and trichloroethene and sub-
samples were subsequently enriched on other chlorinated ethenes, including 1,1-DCE 
(25).  Samples of the 1,1-DCE enrichment culture were used for bioaugmentation of the 
microcosms (1 mL per dose, without concentration, containing approximately 109 cells of 
Dehalococcoides per mL).   
2.3.7 Denaturing gradient gel electrophoresis (DGGE) and protein analysis 
 After lysing samples of the enrichment culture (15), protein levels were 
determined using a Compat-AbleTM assay preparation reagent set and a BCATM protein 
assay kit (Pierce Chemical Company), following the manufacturer’s enhanced protocol.  
Total community DNA was extracted from homogeneous samples of groundwater and 
soil from selected microcosms using an UltraClean® soil DNA isolation kit (MO BIO 
Laboratories, Inc.) by following the manufacturer’s maximum yield protocol. A segment 
of the 16S rRNA gene of the bacteria domain was amplified with universal primer 1055F 
and 1406R with a 40 base GC clamp through an adapted touch-down polymerase chain 
reaction program (18) prior to separation by DGGE (74), with a 0-100% gradient.   
2.3.8 Dissolved organic carbon, organic acids, and anions 
 Dissolved organic carbon (DOC) was quantified using a Shimadzu TOC –VCSH 
TOC analyzer with a combustion catalytic oxidation method (680°C).  Organic acids 
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were analyzed on a Waters 600E HPLC system equipped with a UV/Vis detector (Model 
490E) set at 210 nm and an Aminex® HPX-87H ion exclusion column (300 mm x 7.8 
mm; BioRad).  Eluant (0.01N H2SO4) was delivered at 0.6 mL per min.  Sulfate was 
measured on a Dionex AS50 ion chromatography system equipped a CD25 Conductivity 
detector and a Dionex guard column (AG9-HC, 4 mm x 50 mm) followed by an IonPac® 
AS9-HC anion-exchange column (4 mm x 250 mm).  Eluant (9 mM Na2CO3) was 
delivered at 1.0 mL per min.   
2.4 Results 
2.4.1 Microcosm response to biostimulation and bioaugmentation 
 Bioaugmentation was the most effective treatment strategy for the high 
concentration plume, followed by biostimulation with corn syrup + B12. iostimulation 
without B12 was much less effective. The performance of representative microcosms for 
the two treatments with B12 added is shown in Figure 2-1.  Complete results for all of the 
microcosms are provided in Appendix A.    
In the biostimulation treatments with high halomethane levels (Figure 2-1a), B12 
was added on days 0, 321, 442 (10 µM/dose), and days 679 and 1016 (30 µM/dose); the 
total amount added was 1.3 mole percent of the total halomethanes added.  CT 
transformation started after a lag phase of 48 days and was completed by day 180. Close 
to that time, transformation of CFC-11 started, decreasing from 90.3 µmol/bottle (29.1 
mg/L) to 10.9 µmol/bottle (3.5 mg/L) on day 897, with relatively little further decrease 
thereafter.  A minor proportion (approximately 1.5%) of the CFC-11 was converted to 
HCFC-21. A notably faster rate of CF transformation started close to day 803, when 
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CFC-11 had decreased to 4.4 mg/L. As a result, the remaining 124 µmol/bottle (234 
mg/L) of CF was removed to below its MCL, i.e., 80 µg/L, by day 1052. Formation of 
DCM, CM, methane and CS2 was minor.  Although there was a gradual decrease in 1,1-
DCE, this was not accompanied by an increase in dechlorination products, suggesting the 
loss occurred predominantly via diffusion (see control results below). 
 The high concentration bioaugmentation microcosms initially received only corn 
syrup (without B12) and were incubated for 193 days prior to bioaugmentation (Figure 2-
1b).  During this interval, the extent of halomethane and 1,1-DCE removal was similar to 
the microcosms with corn syrup added (Appendix A.1), i.e., some losses of CT, CF and 
1,1-DCE occurred, while there was virtually no loss of CFC-11. The first 
bioaugmentation of the SRB lactate culture substantially improved th  rate of CT 
removal.  The rate of CT removal increased further in response to the first dose of B12 (10 
µM) on day 230, completing transformation of CT by day 255. During this interval, the 
lactate added was converted to acetate in a nearly one to one molar ratio. Thereafter, 
propionate started to become the dominant product from lactate, rather than acetate 
(Appendix A.8), indicating the onset of a fermentation pathway. Biotransformation of the 
CFC-11 began once the CT was nearly gone, accompanied by an increase in CS2, an 
indirect indication of the availability of sulfide.  HCFC-21 also increased via 
hydrogenolysis.  The amount of CS2 and HCFC-21 formed accounted for approximately 
17% of the CFC-11 consumed until a second bioaugmentation using an ethanol-grown 
SRB enrichment culture was applied on day 293. Although the increase of CS2 and 
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accumulation of propionate ceased following the additions of ethanol and ferrous 
chloride, it failed to restore a high transformation rate.  
 Transformation of CFC-11 and CF either diminished or stopped until the third 
bioaugmentation with a fermentative enrichment culture together with the second dose of 
B12 (10 µM) on day 490, which had an immediate effect. The remaining 1.6 µmol/bottle 
(2.4 mg/L) of CFC-11 was removed by day 613. Two more doses of the ferm ntative 
culture were added to sustain a high rate of CF transformation.  Transformation of the 
143 µmol/bottle (271 mg/L) of CF remaining on day 490 was completed by day 675.  
During this interval three more doses of B12 were added, resulting in a total B12 dose of 
1.4 mole percent of the total halomethanes added.  After the CF was consumed, the 
previously accumulated DCM and HCFC-21 decreased. Unlike the treatments without 
bioaugmentation (Figure 2-1a), the remaining 6.7 µmol/bottle (4.5 mg/L) of 1,1-DCE 
was removed by bioaugmentation with an approximately stoichiometric amount of ethene 
formation; a low level of VC appeared transiently.  A notable amount of methane was 
produced in this interval (148-242 µmol/bottle; not shown in Figure 2-1b); prior to 
removal of the halomethanes, methanogenesis was completely inhibited. 
 Both treatments receiving B12 achieved complete transformation of CT and CF. 
However, biostimulation with corn syrup + B12 was less efficient in terms of the total 
amount of CFC-11 removed, i.e., 93% versus 100% by bioaugmentation.  Biostimulation 
with corn syrup, lactate, and vegetable oil without B12 was less effective, but all achieved 
complete transformation of CT, 37-45% removal of CFC-11 and 80-84% removal of CF. 
The 80% decrease of CT achieved in the as-is treatment (no substrate added) is 
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significantly higher than those in the controls (AC and WC), i.e., 18%. However, the 
decreases of CFC-11 (7%), CF (14%), and 1,1-DCE (26%) observed in the as-is 
treatment  were comparable to those in the controls, indicating the loss s were mostly 
diffusive. In contrast to the complete removal of 1,1-DCE achieved in bioaugmentation, 
approximately two thirds of 1,1-DCE was removed in all of the biostimulation treatments. 
Lack of formation of daughter products, however, suggests the loss occurred 
predominantly via diffusion. 
 Representative results for microcosms prepared with medium concentrations of 
halomethanes that were subjected to biostimulation with corn syrup + B12 and 
bioaugmentation are shown in Figure 2-2.  The biostimulation treatments received B12 
(10 µM) on days 0 and 448.  The total amount of B12 added was 2.6 mole percent of the 
total halomethanes added.  As Figure 2-2a shows, transformation of the 8 µmol/bottle 
(7.5 mg/L) CT started after a lag phase of 53 days and was completed on day 146. 
Transformation of the CFC-11 followed immediately once CT was gone. Th  13 
µmol/bottle (4.5 mg/L) of CFC-11 decreased to 0.23 µmol/bottle (73 µg/L) by day 502. 
A minor amount of HCFC-21 (2% molar ratio of the CFC-11 transformed) accumulated. 
There was no accumulation of HCFC-31 or CS2.  Activity on CF started along with the 
CFC-11 transformation and accelerated on day 445 when the CFC-11 was nearly gone. 
The 1,1-DCE respiring culture was bioaugmented once the CF dropped below its MCL 
on day 544, and the remaining 0.18 µmol/bottle (118 µg/L) of 1,1-DCE was removed 
below its MCL (i.e., 7 µg/L) in 55 days.  A low level of VC appeared transiently. The 
performance of this microcosm suggests that the plume with medium concentration levels 
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of halomethanes may be remediated by biostimulation with corn syrup + B12 in 
approximately 600 days. 
 The medium concentration bioaugmentation microcosms initially receiv d only 
corn syrup and were incubated for 143 days prior to bioaugmentation with the SRB 
lactate enrichment culture along with the first dose of B12 (10 µM) (Figure 2-2b). The 
response was immediate.  The rate of CT removal increased substantially and removal 
was complete by day 196. CS2 started to accumulate.  Acetate was the predominant 
product of the lactate consumption during this interval, although propionate star d to 
increase (Appendix A.8).  CFC-11 biodegradation began as CT levels decreased and the 
rate of removal significantly accelerated in the interval of day 216 to 292, after CT was 
completely consumed.  In this interval, CFC-11 decreased from 7.7 µmol/bottle (2.5 
mg/L) to 0.54 µmol/bottle (0.2 mg/L). CS2 increased during this interval and a minor 
amount of HCFC-21 also accumulated.  The amount of CS2 formed accounted for 34% of 
the CT and CFC-11 consumed.  Lactate was increasingly converted to propi nate rather 
than acetate (Appendix A.8).  The second bioaugmentation dose using the SRB thanol 
culture was implemented on day 293 to prevent any further increases in CS2, enhance 
sulfate reducing activity, and accelerate CF removal.  Addition of ferrous chloride along 
with ethanol curbed the increase in CS2 and the ethanol-enriched culture stopped 
producing propionate.  Nevertheless, the rate of CF removal did not change demonstrably 
and close to day 367 the rate of removal started to decline until the hird bioaugmentation 
dose with the fermentative culture grown on corn syrup, plus a second dose of B12 (10 
µM) on day 490. The remaining 3.5 µmol/bottle (6.6 mg/L) of CF was reduced to below 
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the MCL by day 613. The total amount of B12 added was 3.1 mole percent of the total 
halomethanes added. Similar to the biostimulation with corn syrup + B12 microcosms, the 
residual 1,1-DCE was removed by bioaugmentation with the chloroethene respiring 
culture, which also corresponded to the onset of methanogenic activity.  
 The two treatments that received B12 achieved complete transformation of the 
three halomethanes, with the exception of 98% removal of CFC-11 in the biostimulation 
treatment with corn syrup + B12.  Among the biostimulation treatments without B12, the 
microcosms with corn syrup achieved complete removal of CT and approximately 35%, 
57%, and 66% removal of CFC-11, CF and 1,1-DCE, respectively. In the microcosms 
with lactate and with emulsified vegetable oil, the percent removals for CT, CFC-11, and 
1,1-DCE were approximately 10% lower.  In the as-is treatment, CT decreased by 54%, 
CF by 27%, , 1,1-DCE by 72%, and no significant decrease in CFC-11 was observed. 
Losses of all compounds from the medium concentration AC microcosms were 18% or 
lower.  
 The microcosms with low concentrations of halomethanes (but no 1,1-DCE) 
behaved similarly to the high and medium concentration treatments. Bioaugmentation 
achieved complete transformation of the three halomethanes in approximately 300 days 
while biostimulation with corn syrup + B12 required 300-600 days. Biostimulation with 
corn syrup was overall the best among the three treatments without B12, i.e., 88% and 
21% decreases in CT and CFC-11, respectively, but no activity on CF. Losses of  
halomethanes from the low concentration AC microcosms were 18% or lower. 
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2.4.2 First order rate constants of halomethane removal 
 CT transformation rates in the bioaugmentation microcosms were three to nine 
times faster than in the biostimulation treatment with corn syrup + B12 (Figure 2-3a).  
Among the biostimulation treatments without B12, corn syrup showed the best overall 
performance, although these rates were notably less than the ones for biostimulation with 
corn syrup + B12.  The initial concentration of total halomethanes (i.e., low, medium and 
high) did not have a significant effect on the CT transformation rate, perhaps because the 
initial CT concentration among the three plumes was similar.  The exc ption was the 
bioaugmentation treatment with low levels of halomethanes, which had the hig st rate 
of CT transformation.  This suggests that the medium and high concentrations of CFC-11 
and CF may have had an inhibitory effect on the rate of CT transformation. 
 For CFC-11, only the two treatment strategies with B12 added were effective. 
Removal rates in the bioaugmentation treatment in each concentration nge for the 
bioaugmentation treatment were approximately two to three times faster than for the 
biostimulation treatment with corn syrup + B12 (Figure 2-3b).  That the highest rate 
occurred in the low concentration plume may indicate an inhibitory effect rom the 
increasing concentrations of CFC-11 and/or CF. 
 With CF, the transformation rates for bioaugmentation were significantly higher 
than for the biostimulation treatment with corn syrup + B12 for the high and low 
concentration microcosms, while they were equivalent for the medium concentration 
microcosms (Student t-test, α=0.05).  CF transformation rates in the other live treatments 
were much lower. The initial concentration of halomethanes appears to have had a 
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modest inhibitory effect on the CF transformation rate in the bioaugmentation treatment, 
while there was no apparent trend in the biostimulation treatment with corn syrup + B12.   
2.4.3 Distribution of products from [14C]CT and [14C]CF  
 CO2, sNSR, and pNSR were the main products of [
14C]CT transformation in the 
bioaugmentation treatment in microcosms for all three concentration r nges (Table 2-3). 
In addition, a significant amount of CS2 was formed in the low concentration microcosms, 
but decreased in the medium and high concentration bottles.  In the biostimulation with 
corn syrup + B12 treatment, CO2, sNSR, pNSR were predominant in the low and medium 
concentration microcosms, with an even larger percentage of CO2 than for the 
bioaugmentation treatment. CO, however, was predominant in the high concentration 
microcosms (i.e., 35%), followed by sNSR. In the biostimulation treatmnts without B12 
added, the main 14C compounds recovered were CT, CF, and NSR, reflecting both 
incomplete conversion of CT and the prevalence of reductive dechlorinati n of CT to CF.  
Losses of 14C ranged from 21-55%, reflecting the long incubation times (i.e., up to 1200 
days). 
 The predominant products of [14C]CF transformation in the bioaugmentation 
treatment were CO2 and sNSR in microcosms for all halomethane concentrations (Table 
2-4). DCM was notable only in the low concentration bioaugmentation microcosms, most 
likely due to the use of the lactate-grown SRB culture, which tended to favor reductive 
dechlorination. In the biostimulation treatment with corn syrup + B12, the main 
14C 
compounds recovered were CO, CO2 and sNSR, with CO predominant in the low and 
high concentration microcosms. Unconverted CF and sNSR were the main fractions for 
 34
the biostimulation treatments without B12 added.  Losses of 
14C ranged from 22-68%, 
reflecting the long incubation times (i.e., up to 1250 days).  
 Untransformed [14C]CT or CF was the main component in both as-is and AC 
treatments, followed by NSR. Significant amounts of CO2 (24%) formed from [
14C]CT in 
high concentration as-is treatment, reflecting the potential for a limited level of natural 
attenuation. The relatively lower losses in as-is and AC treatm nts in the medium and 
high concentration microcosms is most likely due to less frequent sampling and, therefore, 
fewer puncture holes in the septa, thereby reducing the diffusive losses.  
 The composition of sNSR recovered in microcosms that received [14C]CT and 
[14C]CF was similar in the bioaugmentation treatment, i.e., 22-44% of the sNSR was 
propionate and 19-26% was acetate, at each halomethane concentration.  Min r amounts 
of formate, ethanol, iso-butyrate and butyrate were detected (i.e., less than 9% of sNSR). 
In the biostimulation treatment with corn syrup + B12 for the medium concentration 
microcosms, acetate was the principal fraction of the sNSR recovered from [14C]CT (53-
60% of sNSR), followed by propionate (11-15% of sNSR).  Formate was the 
predominant organic acid formed in the high concentration microcosms (38% of sNSR), 
followed by lactate (20% of sNSR) and propionate (11% of sNSR). Acetate was 
predominant in the sNSR recovered from [14C]CF in the medium concentration 
biostimulation treatment with corn syrup + B12 (50% of sNSR), while propionate 
dominated in the high concentration microcosms (28% of sNSR), followed by formate 
(13% of sNSR) and acetate (10% of sNSR). The organic acid composition of sNSR 
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formed from [14C]CF in the biostimulation treatments without B12 in the medium and 
high concentration microcosms were similar, with acetate and propionate predominant.   
2.4.4 Electron donor utilization and sulfate consumption  
 DOC consumption was used as a surrogate for electron donor utilization.  The 
background DOC level in the groundwater for the three plumes was less than 100 mg/L, 
so nearly all of the DOC present in the microcosm was from the substrate added.  Table 
2-5 shows the amount of DOC added and consumed.  The highest decrease in DOC 
occurred with emulsified vegetable oil in all plumes, representing 80-84% of the DOC 
added.  However, this was most likely due to adsorption of the oil to the soil, leaving very 
low amounts of substrate in the aqueous phase.  DOC consumption in the trea ments with 
corn syrup only and corn syrup + B12 was similar, representing up to one third 
consumption of the DOC added in the low and medium concentration microcosms, and 
12-20% consumption in the high concentration microcosms.  DOC utilization in the 
bioaugmentation treatment ranged from 7-25% of the DOC added. Lactate was the least 
efficiently used electron donor for biostimulation, with negligible use in both low and 
high concentration microcosms and 20% decrease in DOC in the medium concentration 
bottles.  
 Table 2-5 also lists the amount of DOC removed per amount of halomethanes 
initially present.  The treatments with corn syrup added had the highest ratios, reflecting 
better utilization of the substrate in the presence of the halomethan s.  The highest ratios 
shown, for emulsified vegetable oil, are a consequence of loss of DOC to adsorption.   
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 The highest amount of organic acid accumulation occurred in the 
bioaugmentation treatment in each concentration range, with similar amounts of acetate 
and propionate present (35-38% of the COD added, respectively).  The total 
accumulation of organic acids accounted for 85-90% of COD added in the low 
concentration microcosms, and approximately 67% in the medium and high 
concentration bottles.  Accumulation of propionate following addition of the SRB lactate 
culture suggested that sulfate reduction was no longer predominant and was replaced by 
fermentation of lactate to propionate.  In the treatments with corn syrup added (with and 
without B12), the COD of the organic acids accounted for 47-57% of the total COD added 
in the medium and high concentration microcosms and 22-60% in the low concentration 
bottles. Acetate was almost the only organic acid formed in the medium and low 
concentration microcosms (with a minor amount of propionate also present in the low 
concentration bottles); in the high concentration microcosms, acetate also predominated 
but other organic acids were also detected. In the treatment with lactate added, nearly all 
of the lactate remained at the end of the incubation period in most of the microcosms.  In 
the treatments biostimulated with emulsified vegetable oil, there was no significant 
accumulation of organic acids at any halomethane concentrations, indicating that the 
decrease in DOC was mainly a consequence of adsorption of the oil.    
 The sulfate initially present in the groundwater was completely removed (i.e., 98-
100%) in the bioaugmentation treatment for the high and medium concentration 
microcosms, with a lower percent removal in the low concentration mcrocosms (42%) 
(Table 2-5).  In the biostimulation treatments with corn syrup + B12, sulfate removal 
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averaged 13%, 42%, and 14% in the high, medium and low concentration bottles, 
respectively.  In the biostimulation treatments with corn syrup alone, sulfate removal 
averaged 100%, 33%, and 18%, in the high, medium and low concentration microcosms, 
respectively.  Sulfate consumption in the biostimulation with lactate or emulsified oil 
treatments was the lowest, varying from zero to 20%.  The lower level of sulfate 
consumption in the lactate treatments coincided with insignificant amounts of DOC 
removal (Table 2-5).   
2.4.5 DGGE  
 When incubation of the microcosms was complete, DNA was extracted and 
analyzed by DGGE (Figure 2-4).  In the as-is treatment (lanes 1, 4 and 7), bands e, f and i 
were common.  At the higher concentration of halomethanes, two additional bands were 
also evident in the as-is treatment (g and h).  At the low and mediu  concentrations, 
biostimulation with corn syrup (lanes 2 and 5) and with corn syrup + B12 (lanes 3 and 6) 
significantly changed the microbial structure in comparison to the as-is treatments (lanes 
1 and 4), i.e., bands a, b, c, and d became prominent while bands e and f were no longer 
evident (except in the corn syrup treatment with low halomethanes, lane 2).  In contrast, 
the biostimulated treatments for the high concentration microcosms (lanes 8 and 9) 
remained similar to the corresponding as-is treatment (lane 7); the only notable exception 
was the appearance of band b in the corn syrup + B12 treatment (lane 9).   
2.5 Discussion 
 This microcosm study demonstrated for the first time that biostimulation and 
bioaugmentation are feasible remediation strategies for in situ treatment of high 
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concentrations of halomethanes and subsequent removal of 1,1-DCE by bioaugmentation.  
All previous microcosm or field studies on bioremediation of halomethanes examined 
concentrations in the low mg/L level (21, 23, 24, 31, 63, 64, 79).  Complete 
biotransformation of halomethanes in the microcosms with high concentratio s was 
achieved in approximately 500 days using bioaugmentation (from time that the first 
bioaugmentation dose was added; Figure 2-2b).  The time required for biostimulation 
with corn syrup + vitamin B12 was approximately twice as long (Figure 2-2a).   
 Unlike chlororespiration, biotransformation of halomethanes is a cometabolic 
process, resulting in less efficient use of the electron donors (67). Prediction of primary 
substrate requirements is, therefore, less certain.  This is epecially true for anaerobic 
systems, since the concept of a transformation capacity used with aerobic cometabolism 
has not been widely adapted to cometabolism under anaerobic conditions.  In this study, 
it appears that the amount of primary substrate provided was well in xcess of that 
required based on the considerable excess of DOC remaining at the end of incubation 
(Table 2-5).  The ratio of primary substrate added to the initial amount of halomethanes 
present for the high concentration microcosms ranged from 247 mg DOC/mmol 
halomethanes for biostimulation without B12 to 564 mg DOC/mmol halomethanes for 
bioaugmentation.  Using data from Hashsham and Freedman (47), this ratio was 1,810 
mg DOC/mmol halomethanes for biotransformation of approximately 100 mg/L of CT by 
fructose-grown A. woodii.  The ratio of mg DOC added per mmol halomethanes present 
used in this study was higher for the medium and low concentration microcosms, 
suggesting that much more primary substrate was added to these treatments than what 
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was required.  Additional work is needed to better define the minimum amount of 
primary substrate needed to achieve high rates of halomethane transformation.  However, 
in terms of in situ remediation, this may not be a major concern due to the relatively low 
cost of corn syrup.  
 The bioaugmentation treatments had consistently higher rates of hal methane 
transformation (Figure 2-3).  Since higher amounts of substrate weradded to the 
bioaugmentation treatments than to the biostimulation treatments with corn syrup + B12 
(Table 2-5), the question arises as to whether the higher transfomati n rates are 
attributable to addition of the cultures or the higher level of primary substrate added.  One 
of the complicating factors was the initial amount of sulfate, which was a potentially 
significant source of demand for primary substrate in addition to hal methane 
transformation, especially for the low and medium concentration microcosms.  The 
higher dose of primary substrate given to these microcosms was based in part on the 
expected higher demand for sulfate reduction.  The significant amount of DOC that 
remained at the end of the incubation period suggests that all of the treatments were 
saturated with substrate.  For the bioaugmentation treatments and the biostimulation ones 
with corn syrup added, the ratios of DOC removed (due in part to sulfate reduction) to the 
initial amount of halomethanes present were similar (i.e., approximately 45, 920, and 
1,500 for the high, medium and low concentration bottles, respectively).  This suggests 
that the higher rates observed for bioaugmentation compared to biostimulation were due 
to the cultures rather than the higher amount of primary substrate addition.  For the 
biostimulation treatments that received corn syrup alone versus corn syrup + B12, the 
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amount of substrate added was similar and, therefore, the higher rates observed with B12 
are clearly attributable to the presence of B12.  Higher rates of halomethane 
transformation with B12 addition have been shown previously in several studies (12, 47, 
48).   
 The first-order rate constants for CT biotransformation via bioaugmentation and 
biostimulation with B12 observed in this study were comparable to those reported in a 
methanogenic sludge consortium (0.5 g VSS/L) with 1-2 mol% B12 in transforming 15 
mg/L CT (i.e., 0.51 – 0.81 d-1) (41), and those by Pseudomonas sp. strain KC (i.e., 
approximately 0.05-0.15 d-1) (86). The significantly higher (by approximately two orders 
of magnitude) first-order rate constants of three cultures grown on propanediol, dextrose 
or acetate, respectively, in transforming µ /L levels of CT with 10 mg/L B12 (89), was 
likely due to the very high ratios of B12 to CT as well as the low initial CT concentrations. 
The first-order rate constants for aerobic cometabolic transformation of CF by a 
methanotroph in media in the absence of methane (83) was over 100 times high r than 
what were observed via bioaugmentation and biostimulation with B12 in this study. 
However, the initial concentration of CF tested by Speitel et a. (83) was only 100 µg/L. 
The first-order rate constants for CFC-11 biotransformation via bio ugmentation and 
biostimulation with B12 observed in this study were comparable to those reported in 
anaerobic soil in a peat land (11). 
The effect of B12 on the products formed from transformation of CT and CF in 
this study was similar to previous findings (12, 47, 48).  With B12 present CO, CO2 and 
NSR were the predominant products.  No previous studies were found that evaluat d the 
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effect of B12 on CFC-11 anaerobic transformation.  At low mg/L concentrations of CFC-
11 and in the absence of B12, the predominant transformation product formed by 
Methanoscarcina barkeri (57) and sulfate reducing bacteria (82) was HCFC-21.  In this 
study, biotransformation of CFC-11 (at initial concentrations that were one order of 
magnitude higher) was fastest in the bioaugmented and biostimulated treatments with B12 
added, although HCFC-21 was a minor product.  This suggests that B12 had the same 
effect on altering the transformation pathway for CFC-11 as itdid for CT and CF, i.e., by 
favoring substitutive and hydrolytic pathways over hydrogenolysis.     
 Among the biostimulation treatments without B12 added, corn syrup was slightly 
more effective for CT transformation.  Metabolism of corn syrup was confirmed by DOC 
removal, sulfate reduction, and accumulation of organic acids.  Formation of acetate, 
propionate, formate, and lactate, was consistent with mixed acid fermentation (53, 69), 
while formation of propionate may have been a consequence of succinate 
decarboxylation (44).  Low redox conditions were also established fastest with corn syrup.  
In contrast, less lactate was consumed (based on DOC removal and HPLC data).  With 
emulsified vegetable oil, the lack of significant accumulation of organic acids and lower 
levels of sulfate reduction suggested that it, too, was poorly utilized.  Most of the DOC 
removal with vegetable oil was likely due to adsorption to the soil.  Use of vegetable oil 
in remediation of chlorinated ethenes typically results in a decrease in the aqueous phase 
concentration due to partitioning (75).  However, such an effect was not apparent in this 
study for the halomethanes or 1,1-DCE, even with repeated additions of vegetable oil.  
The only apparent effect of the emulsified vegetable oil was on the product distribution 
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from [14C]CT, i.e., pNSR was generally higher in the treatments with oil added (Table 2-
3).  Although treatments with lactate + B12 and emulsified vegetable oil + B12 were not 
tested in this study, the lack of evidence for significant metabolism of these substrates 
suggests they are not likely to be effective with halomethanes under the conditions 
evaluated.      
 In previous studies of anaerobic transformation of halomethanes, the effectiv ness 
of sulfate-reducing cultures grown on lactate and acetate (36) and acetogenic cultures 
growing on fructose has been demonstrated (47).  Due to the high background 
concentration of sulfate at the industrial site that was a focus of this study, use of a sulfate 
reducing culture for bioaugmentation was evaluated first.  The initial response to 
bioaugmentation with this culture was promising.  However, significat amounts of CS2 
began to accumulate after several weeks.  In the high and medium concentration 
microcosms, the rate of CFC-11 transformation slowed considerably and sulfate 
reduction was replaced by fermentation of the lactate to propionate (59).  To address 
these concerns, a second sulfate-reducing culture was evaluated sing ethanol as a 
substrate and addition of ferrous chloride to mitigate CS2 formation by lowering the 
sulfide concentration.  Based on sulfate consumption and accumulation of stoichiometric 
levels of acetate from ethanol, it was apparent that the culture was active.  How ver, there 
was no improvement in the rate of CFC-11 or CF transformation.  One factor 
contributing to the ineffectiveness of the SRB bioaugmentation cultures may have been 
the toxicity of the halomethanes, especially the high concentration of CF.  Attempts to 
acclimate the ethanol-grown SRB culture to increasing amounts of CF (along with B12) 
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were unsuccessful.  In contrast, the fermentative enrichment grown on corn syrup (along 
with B12) readily acclimated to CF, up to 500 mg/L.  Subsequent additions of this culture 
to the microcosms yielded high rates of CF transformation.  The ability of acetogenic 
cultures to biotransform halomethanes has been attributed to enzymes associated with the 
acetyl-CoA pathway (27).   
 Regardless of the treatments tested, halomethane transformation occurred in a 
consistent order, i.e., CT was consumed first, followed by CFC-11 and the  CF.  This is 
in agreement with thermodynamic expectations for the predominant tr nsformation 
pathways observed in this study, i.e., more free energy is gained by transformation of CT 
versus CFC-11 and more from CFC-11 than CF via reductive hydrolysis and substitution 
or net hydrolysis (Table 2-6).  The free energy change for reductive dechlorination of CT 
and CFC-11 are similar, but this was not a significant pathway.    
 The in situ conditions at the industrial site offered an interesting opportunity to 
observe the microbial community response to pH adjustment and biostimulation.  The 
areas of the site with low and medium concentrations of halomethanes hav  acidic pH 
levels, while the high concentration area is near neutral pH.  DGGE results revealed 
major changes in community structure for the low and medium concentratio  
microcosms.  In contrast, there was comparatively little shift in the structure of the high 
concentration microcosms.  These results suggest that pH was a more significant factor 
than the concentration of halomethanes during the response to biostimulation.  Lei and 
VanderGheynst (62) also observed a significant effect of pH adjustment on microbial 
structure during composting.  Apparently microbes in the high concentratio  area at the 
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industrial site have acclimated to the presence of high levels of hal methanes, based on a 
lack of significant change in response to biostimulation.  Furthermor, there was more 
diversity of microbes in the as-is high concentration treatment compared to the medium 
and low concentration microcosms, also an apparent consequence of exposure to different 
pH levels over many decades.   
 Use of bioaugmentation to remove 1,1-DCE was not attempted until the 
halomethanes were removed.  Chlororespiration of 1,1-DCE requires the pres nce of 
Dehalococcoides, which are strongly inhibited by low concentrations of CF during 
reductive dechlorination of tetrachloroethene, trichloroethene, cis-dichloroethene, and 
VC (22, 73). Although the effect of CF on reduction of 1,1-DCE has not been reported, 
inhibition by CF seems highly likely, due to the need for Dehalococcoides to carry out 
the reaction.  Following removal of halomethanes from the high and meiu  
concentration microcosms, bioaugmentation with a 1,1-DCE respiring culture was 
effective.  This confirmed the potential to use bioremediation for complete removal of 
high concentrations of halomethanes, followed by removal of 1,1-DCE. 
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2.6 Tables and Figures 
 
 









 Initial Adjusted 
 
  
High  6.6 7.5 116 0 
Medium  3.3 7.3 1,330 480 
Low  3.5 7.3 1,730 790 




Table 2-2 Target concentrations of halogenated 
contaminants in the microcosms 
 Concentration (mg/L) a 
Compound High  Medium  Low    
CF 500 28 1.8 
CT 8.8 10 6.5 
CFC-11 26 2.9 0.75 
1,1-DCE 9.1 0.11 0 
a The designation of “high” concentration is based on 
CF and CFC-11; CT concentrations were relatively 










% of [14C]CT added 
  CH4 CO CM DCM CS2 CF CT other CO2  sNSR pNSR UA
a loss 
Low bioaugmentation 0.16 0 0.40 2.5 14b 0.94 0.11 2.6 20 15 16 0.65 28 
 corn syrup + B12 0.40 0.09 0.36 1.5 0.28 0.76 0.84 0.38 36 18 15 4.1 21 
 corn syrup 0.01 0.54 0.25 1.3 5.1 13 6.2 0.71 6.2 6.0 25 2.3 34 
 vegetable oil 0.05 0.69 0.29 0.98 0.38 15 19 0.67 2.1 2.0 22 2.1 35 
 lactate 0 0 0.20 1.1 5.1 8.2 23 2.7 4.9 5.4 10 8.0 32 
 as-is 1.4 0.05 0.27 3.1 1.1 3.9 39 1.4 5.5 2.6 9.8 3.7 28 
 AC 0 0 0.71 0.92 0.17 2.6 52 3.1 1.1 0.40 2.6 8.5 28 
Medium bioaugmentation 0.07 0 0.04 0 5.6 0.35 0.02 0.36 18 12 8.5 0 54 
 corn syrup + B12 0.46 0.02 0.44 0.14 1.6 0.20 0.03 0.32 29 13 11 6.8 37 
 corn syrup 0.02 0.01 0.10 0.21 2.8 6.4 0.19 2.6 8.8 7.2 17 0 55 
 vegetable oil 0 0 0.24 1.3 0.11 10 12 0.73 1.2 2.7 41 1.6 28 
 lactate 0.01 0.47 0.07 0.23 0.01 4.9 10 3.5 6.8 7.4 13 5.7 47 
 as-is 0.51 4.9 1.8 0.16 0.03 6.3 25 1.1 6.0 4.3 20 0 30 
 AC 0 0 0.24 0.47 0.12 0.84 60 1.4 0.89 0.51 2.2 1.9 31 
High bioaugmentation 0.99 0 0.12 0.0 2.1 0.0 0.02 0.05 9.1 31 9.2 12 35 
 corn syrup + B12 1.4 35 0.64 0.0 0.36 0.0 0.50 0.33 6.7 18 7.7 0.0 30 
 corn syrup 0 0 0.02 0.0 1.1 2.4 0.05 0.61 6.7 16 18 9.2 47 
 vegetable oil 0 0 0 0.0 0.0 2.3 0.04 0.01 9.1 3.5 49 7.2 29 
 lactate 0.09 2.3 0.46 0.86 0.0 3.5 0 0.19 11 11 23 13 35 
 as-is 0 0 0.07 0 0.27 7.0 11 0.65 24 6.4 18 11 22 
 AC 0 0 0.06 0 0 0.60 52 0.21 1.7 0.32 0.93 0.68 44 
a UA=unaccounted for, i.e., percentage of remaining 14C that cannot be assigned to a particular compound or category.  














% of [14C]CF added 
  CH4 CO CM DCM CS2 CF CT other CO2  sNSR pNSR UA
a loss 
Low bioaugmentation 0.08 0 0.40 24
b 4.9 0.91 0.06 0.71 11 15 7.7 1.0 35 
 corn syrup + B12 0.42 34 1.3 1.8 0.15 0.86 0.04 0.48 13 14 7.5 0.41 27 
 corn syrup 0 0 0.13 1.5 0.23 53 0.54 0.43 1.7 11 9.5 0.87 22 
 vegetable oil 0 0 0.09 1.4 0.12 46 0.63 0.53 2.2 7.6 7.5 1.3 33 
 lactate 0 0 0.20 1.2 0.10 48 0.63 0.34 2.2 10 6.3 0.75 30 
 as-is 0 0 0.17 2.3 0.18 59 1.2 0.50 1.5 7.6 8.7 5.8 13 
 AC 0.08 0.10 0.28 2.8 0.16 60 1.2 0.41 3.6 6.1 5.6 7.4 12 
Medium bioaugmentation 0.15 0 0.04 0.09 0.44 0.05 0.02 0.31 24 19 2.2 0 54 
 corn syrup + B12 0.23 0.06 0.05 0.04 0.06 0.25 0.01 0.11 31 14 4.0 0 50 
 corn syrup 0 0 0.01 0.03 0.04 16 0.05 0.14 3.0 11 1.4 4.5 64 
 vegetable oil 0.49 19 0.54 2.8 0 7.3 0 1.75 3.1 11 2.9 0 51 
 lactate 0 0 0.06 0.03 0.07 19 0.03 0.11 3.9 9.9 1.6 3.58 62 
 as-is 1.5 14 1.7 0.09 0.44 35 0.70 0.75 4.2 10 3.6 0 28 
 AC 0 0 0 0.20 0.08 59 0.67 0.50 3.7 8.3 4.8 7.7 15 
High bioaugmentation 1.3 0 0.06 0.11 0.15 0.05 0.0 0.22 13 32 5.6 5.1 42 
 corn syrup + B12 0.26 37 0.30 0.35 1.2 0.0 0.0 0.39 1.8 13 1.0 0.0 44 
 corn syrup 0.0 0.0 0.0 0.0 0.13 15 0.0 0.14 1.6 13 1.8 1.2 67 
 vegetable oil 0.06 0.32 0.0 0.07 0.07 12 0.0 0.20 3.0 9.3 3.0 5.8 66 
 lactate 0.0 0.0 0.0 0.0 0.17 13 0.0 0.19 0.9 14 3.7 0.5 68 
 as-is 0.14 2.6 0.04 0.60 0.10 58 0.22 0.26 4.5 11 3.5 1.1 18 
 AC 0.06 0 0 0.59 0.14 64 0.98 0.24 3.6 7.8 1.9 4.4 17 
a UA=unaccounted for, i.e., percentage of remaining 14C that cannot be assigned to a particular compound or category.  



























 initial     removed 
Low bioaugmentation 3,020 340 15,000 1,690 3,680 1,530 
 corn syrup + B12 1,140 239 5,660 1,190  522 
 corn syrup 1,110 323 5,500 1,600  651 
 vegetable oil 772 649 3,830 3,220  543 
 lactate 1,110 8 5,500 40  163 
Medium bioaugmentation 3,440 846 5,010 1,230 2,740 2,680 
 corn syrup + B12 1,620 542 2,360 787  1,140 
 corn syrup 1,470 505 2,140 733  904 
 vegetable oil 1,020 821 1,490 1,190  0 
 lactate 1,470 292 2,140 424  548 
High bioaugmentation 4,000 279 564 38 443 443 
 corn syrup + B12 2,250 265 317 36  57 
 corn syrup 2,060 404 291 55  443 
 vegetable oil 1,750 1,160 247 157  59 




Table 2-6 Reactions involved in the transformation of 
halomethanes and associated Gibbs free energy 
changesa 
Reactions   ∆G°'  
Reductive dechlorination   
CCl4 + H
+ + 2e- →  CHCl3 + Cl
- -102.2 
CCl3F + H
+ + 2e- → CHCl2F + Cl
- -103.2 
CHCl3+ H
+ + 2e- → CH2Cl2 + Cl
- -84.5 
Reductive hydrolysis    
CCl4 + 2e
- + H2O →  CO + 2H
+ + 4Cl- -424.7 
CCl3F + 2e
- + H2O →  CO + 2H
+ + 3Cl- + F- -415.4 
CHCl3 + 2e
- + H2O  →  HCHO + H
+ + 3Cl- -244.9 
Substitution or net hydrolysis   
CCl4 + 2HS
- →  CS2 + 2H
+ + 4Cl- -501.2 
CCl3F + 2HS
- →  CS2 + 2H+ + 3Cl
- + F- -474.7 
CHCl3 + H2O →  CO + 3H
+ + 3Cl- -339.6 
a 25°C, reactants and products at 1M or 1 atm except for 
H+ at pH 7.0; free energies of formation were obtained 





























Figure 2-1 Representative performance of microcosms with high concentrations of 
halomethanes, treated by biostimulation (a) and bioaugmentation (b); arrow= 
addition of electron donor (↓=corn syrup, ↓= lactate, ↓= ethanol);   =addition of 
culture (C1= lactate SRB, C2= ethanol SRB, C3=corn syrup fermentative, and 
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Figure 2-2 Representative performance of microcosms with medium concentrations 
of halomethanes, treated by biostimulation (a) and bioaugmentation (b); arrow= 
addition of electron donor (↓=corn syrup, ↓= lactate, ↓= ethanol;   =addition of 
culture (C1=SRB lactate, C2=SRB ethanol, C3=corn syrup fermentative, and 
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Figure 2-3 Comparison of first-order rate constants for CT (a), CFC-11 (b), and CF 
(c) with different treatments, for high, medium and low concentrations.  Error bars 









































































































































Figure 2-4 DGGE results for biostimulation microcosms. Lanes 1-3 are for 
microcosms with low concentrations of halomethanes, 4-6 for medium 
concentrations, and 7-9 for high concentrations; lanes 1, 4 and 7 are for the as-is 
treatment; lane 2, 5 and 8 are for biostimulation with corn syrup; and land 3, 6, and 
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3. ANAEROBIC BIOTRANSFORMATION OF HIGH CONCENTRATIONS OF 
CHLOROFORM BY AN ENRICHMENT CULTURE AND TWO ISOLATES  
3.1 Abstract 
  Bioremediation of high concentrations of chloroform (CF) in groundwater 
remains highly challenging because of its extremely high toxicity and inhibitory effect on 
most anaerobic prokaryotes. The overall objective of this research is to develop cultures 
that can readily transform hundreds of mg/L of CF and is practical for field application.  
DHM-1, a natural aquifer derived fermentative enrichment culture grown on corn syrup, 
was demonstrated to be able to transform over 500 mg/L CF in the pres nce of catalytic 
amounts of vitamin B12 at a rate as high as 22 mg/L/d in a mineral salts medium. 
Production of non-toxic end products, i.e., CO, CO2, and organic acids indicates 
hydrolytic reactions as the dominating pathway. DHM-1 is faculttive, anaerobic and can 
grow on corn syrup while transforming high concentrations of CF, which makes it a 
promising culture for bioaugmentation.   The two isolates from DHM-1 are both likely 
Pantoea spp., and both possess an equal or even slightly better CF transforming 
capability than DHM-1. Development of DHM-1 and the two isolates suggests that 
bioaugmentation of source zones containing high concentrations of CF may be a feasible 
remediation strategy. 
3.2 Introduction 
 In the 2007 CERCLA Priority List of Hazardous Substances, CF ranks eleventh 
overall, the third highest among chlorinated organics, after vinyl chloride and 
polychlorinated biphenyls (8).  This is a reflection of how frequently CF is detected in 
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groundwater and its high level of toxicity.  When present at hazardous waste sites, CF is 
often a focal point for evaluating the feasibility of bioremediation, since it is very toxic to 
most obligate anaerobic prokaryotes. For example, only 1 mg/L of CF completely 
inhibited tetrachloroethene (PCE) dechlorination by a mixed chlororespiring anaerobic 
culture (73). Inhibition of reductive dechlorination of chloroethenes by CF is a general 
problem for sites co-contaminated with CF, and can only be overcome by first removing 
the CF (73).  
 In spite of major recent advances in bioremediation for chlorinated organic 
compounds, treatment of CF, especially at high concentrations (e.g., >100 mg/L), still 
remains challenging.  Although aerobic biotransformation of CF is possible (e.g., 
cometabolism by a butane-grown strain (30)), CF is even more difficult to cometabolize 
than trichloroethene (88). Biotransformation of CF by mixed or pure cltures under 
methanogenic (9, 43) and sulfate reducing (42) conditions has been reported, h w ver, 
only at low mg/L CF concentrations.  
 Corrinoids such as vitamin B12 (i.e., cyanocobalamin) are effective catalysts for 
increasing the rate of halomethane biotransformation under anaerobic c nditions.  
Addition of vitamin B12 also shifts the pathway away from reductive dechlorination and 
towards hydrolytic and substitutive reactions forming CO, CO2 and organic acids (12, 47, 
48).  With catalytic amounts of B12 added, an enrichment culture grown on 
dichloromethane (DCM) as the sole substrate (12) and a lactate-grown sulfate-reducing 
enrichment culture (36) were able to biotransform up to 260 mg/L and 270 mg/L of CF, 
respectively. However, use of the DCM culture is not feasible for in situ bioremediation 
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because it requires DCM as a growth substrate and only grows well at 35oC. A major 
disadvantage of the lactate-grown culture is the accumulation of DCM during CF 
transformation.   
 The microcosm study described in Chapter 2 demonstrated that bioaugmentation 
is a technically feasible remediation strategy for high concentrations of halomethanes.  Of 
the three enrichment cultures tested, the fermentative one that grows on corn syrup 
showed the most promise for biotransforming CF to environmentally benign products.  
The objectives of this study were 1) to further characterize the fermentative culture in 
terms of its maximum rate of CF transformation, its dependence on B12 for 
transformation of CF, and its ability to grow on corn syrup in the presence of CF; 2) to 
identify the transformation products from CF; and 3) to isolate and identify the microbes 
in the enrichment culture that are responsible for CF biotransformation.   
3.3 Materials and methods 
3.3.1 Chemicals, radioisotopes and culture media  
CF (99.7%, Shelton Scientific) and DCM (99.9%, AlliedSignal) were obtained as 
neat liquids.  CF was added to serum bottles as either a water saturated solution (to 
provide up to 15 mg/L) or as a neat liquid (to provide up to 500 mg/L).  Chloromethane 
(CM; 99%, Praxair) and methane (99.99%, Matheson) were obtained as neat gas s.  Corn 
syrup (regular type, Sweetener Products Company) was used as the primary substrate.  
The chemical oxygen demand (COD) for corn syrup was calculated based on its 
presumed composition, i.e., C6H12O6.    Cyanocobalamin (i.e., vitamin B12, USP grade) 
was obtained from Research Organics, Inc.  All other reagents were ACS grade or higher.  
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Neat [14C]CF (0.5 mCi/mmol) was purchased from American Radiolabeled Chemicals, 
Inc. and a stock solution was prepared in distilled deionized water (app oximately 107 
disintegrations per minute (dpm) per mL).   
 A previously described (32) mineral salts medium (MSM) was used, with the 
following modifications:  NaCl and KH2PO4 were not added; the concentration of 
K2HPO4 and NaHCO3 was changed to 0.41 g/L and 4.0 g/L, respectively; and the 
headspace consisted of  30% CO2 and 70% N2 instead of helium.  Sodium sulfide (0.5 
mM) was added to the MSM inside an anaerobic chamber.  Pure cultures we e grown in 
filter sterilized MSM and stock solutions of corn syrup, sodium sulfide, and B12 (0.45 
µm).  Tryptic soy agar (TSA) was obtained from MO BIO Laboratories, Inc. 
3.3.2 Development of an enrichment culture acclimated to CF  
An enrichment culture was started in the absence of CF by combining soil (20 g) 
from an uncontaminated area of the industrial site as inoculum, MSM (100 mL) and corn 
syrup (40 mM) as the primary substrate.  The bottles were prepared in an anaerobic 
chamber containing an atmosphere of approximately 98% N2 and 2% H2.  After 1-2 
weeks of incubation, the protein level reached 200 µg/mL and a 1% transfer wa  made to 
MSM and corn syrup.  When protein again reached 200 µg/mL, the culture was 
concentrated by centrifugation (5500 g) and resuspended in MSM (200 mL) plus corn 
syrup in a 250 mL bottle sealed with a Teflon-lined rubber septum and screw cap.  
Acclimation to CF began by adding 2.8 µmol per bottle.  Taking into acc unt partitioning 
to the headspace (see below), the aqueous phase concentration was 1.5 mg/L.  The initial 
dose of vitamin B12 was 10 µM.  As CF was transformed, increasing amounts of CF were 
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added. B12 was added along with CF to maintain a 3% molar ratio of B12 to cumulative 
CF added. Periodic additions of corn syrup were made when there was a cessation of a 
decrease in pH, i.e., a decrease in pH indicated that fermentation was occurring due to 
accumulation of organic acids (predominantly formate, acetate and propionate), so when 
the pH stopped decreasing, more corn syrup was added (approximately 960 mg COD/L 
per dose).  When the pH decreased to 6.7-7.0, it was raised to 7.5-7.7 with 8 M NaOH.   
After consuming a single dose of 500 mg/L of CF, a 1% transfer of the 
enrichment culture was made to MSM plus corn syrup (960 mg COD/L ), B12 (136 µM ) 
and CF (36 µL neat = 452 µmol per bottle, or an aqueous phase concentration of 500 
mg/L) in 160 mL serum bottles with 100 mL of liquid phase.  When the CF remaining 
was below 0.5 mg/L, further enrichment of the culture was achieved by sequential 1-5% 
transfers along with the same initial conditions for CF, B12 and corn syrup.  The amount 
of corn syrup needed gradually decreased so that by the 13th transfer of the culture, only 
one dose (960 mg COD/L ) was made at the start.  The enrichment culture obtained was 
designated DHM-1.   
3.3.3 Pure culture isolation and acclimation to CF 
Samples of DHM-1 were streaked on TSA and incubated (35°C) aerobically for 
24 h.  Well isolated colonies were returned to MSM + corn syrup + CF + B12 and 
incubated anaerobically.  When CF transformation was complete, the process was 
repeated (i.e., restreaking, aerobic growth on TSA, and return of isolated colonies to 
liquid culture under anaerobic conditions).  Samples from the resulting bottles were again 
restreaked and grown on TSA for up to 48 h.  At this point, two morphologies were 
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identified; one was a larger white (slightly yellow) colony (1-2 mm) that grew more 
quickly (i.e., within 24 h), the other a smaller yellow colony (≤ 1 mm) that grew more 
slowly (i.e., within 48 h).  Samples of both colonies were restreaked on TSA four to 
seven times before returning the isolates to MSM with CF.  The purity of the isolates was 
confirmed based on microscopic observation and sequencing of their 16S rRNA genes 
(see below).   
Once the isolates were obtained, they were exposed to CF again, as follows.  
Single colonies from plates were used to inoculate MSM.  Corn syrup was added, the 
headspace was purged with a mixture of 70% N2 and 30% CO2, and the cultures were 
allowed to grow for 24-48 h on a shaker table in the absence of CF orB12.  Neat CF and 
B12 were then added and the bottles were incubated for 2-3 days on a shaker table to 
ensure that the neat CF dissolved.  The bottles were then maintained as d scribed in the 
section on CF biotransformation.  In subsequent transfers of the cultures to MSM (5% 
v/v), growth on corn syrup prior to CF addition was no longer considered necessary, i.e., 
the CF, B12 and corn syrup were added at the same time as inoculation.  The purity of the 
cultures was routinely checked by streaking on TSA.   
3.3.4 CF biotransformation  
CF biotransformation experiments were performed in160 mL serum bottles, 
which were prepared in an anaerobic chamber.  After dispensing MSM (93 mL) and 
inoculating the bottles (5 mL of DHM-1 or the isolates), they were r moved from the 
chamber.  Corn syrup and B12 were added (yielding a total liquid volume of 100 mL) to 
provide initial concentrations of 960 mg COD/L and 0.136 mM (i.e., 3 mole percent of 
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the total CF), respectively.  The headspace was then purged for 1 min with a gas mixture 
(30% CO2/70% N2) and the bottles were sealed with Teflon-lined red rubber septa and 
aluminum crimp caps.  CF was then added; the amount was confirmed gravimet ically.  
The bottles were incubated for 2-3 days on a shaker table to ensure that the neat CF 
dissolved.  They were then transferred to the anaerobic chamber, where they were 
incubated quiescently, in an inverted position and shielded from light.  The bottl s were 
removed weekly to monitor and adjust pH as needed (to stay in the range of 6.7-7.7), add 
corn syrup as needed, and remove headspace samples for gas chromatographic analysis.  
They were shaken vigorously prior to headspace sampling to ensure that the aqueous and 
headspace phases were in equilibrium.   
 One of the CF biotransformation experiments was performed using[14C]CF along 
with CF, thereby allowing for measurement of the 14C products formed.  In order to 
minimize addition of any 14C-labeled impurities, aliquots of the [14C]CF stock solution 
(60 µL) were injected onto a gas chromatograph (GC) containing a stainless steel column 
(3.175 mm × 2.44 m) packed with 1% SP-1000 on 60/80 Carbopack B (Supelco). N2 was 
used as the carrier gas (28.5 mL/min at 150°C). The outlet of the column was connected 
to stainless steel tubing (1.59 mm) that exited the GC oven and terminated with a needle, 
which was inserted into the microcosm headspace during the interval when CF eluted 
(6.35-6.85 min). The total 14C added was approximately 0.45 µCi/bottle. 
3.3.5 Analytical methods and 14C distribution  
CF, DCM, CM, and methane were monitored by gas chromatographic analysis of 
0.5 mL headspace samples, as previously described (35). A Hewlett Packard 5890 Series 
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II GC equipped with a flame ionization detector was used.  A response factor for each 
compound was measured to relate the total mass present in a bottle to the GC peak area 
(38).  Aqueous phase concentrations were calculated based on Henry’s law constants at 
23°C and the volume of headspace (60 mL) and liquid (100 mL) per bottle (35).  The 
detection limits are approximately 10, 9, and 1 µg/L for CF, DCM and CM, respectively.  
 The total amount of 14C in the bottles was quantified by counting samples of the 
headspace (0.5-mL) and liquid (0.1-mL) in liquid scintillation cocktail (LSC). 
Distribution of the 14C-labeled compounds (DCM, CM, CO and methane) was 
determined by a combination of headspace and aqueous-phase analyses (33, 35).  Volatile 
compounds (DCM, CM, CO and methane) were analyzed with a GC/combustion 
technique.  A 0.5-mL headspace sample was injected onto the Carbopack clumn and the 
well-separated compounds were routed to a catalytic combustion tube (containing CuO), 
where the compounds were oxidized at 800°C to CO2.  Each fraction was then trapped in 
3 mL of 0.5 M NaOH and counted in 15 mL LSC.  A second headspace sample was 
injected onto a stainless steel column (2.44-m by 3.175-mm) packed with Carbosieve SII 
(Supelco) to separate methane, CO and CO2, which were not adequately separated by the 
Carbopack column.     
 14CO2 and 
14C-labeled nonvolatile compounds were measured after analysis of the 
14C-labeled volatile compounds was completed. After raising the pH of the liquid to drive 
the CO2 in headspace into the liquid phase (by adding 0.75 mL of 10 M NaOH), samples 
of the liquid phase (10 mL) were transferred to a test tube that was connected to a second 
test tube containing 10 mL 0.5 M NaOH. Nitrogen gas was sparged into the first tube and 
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over into the second. The pH in the first tube was then lowered by injecting 0.25 mL of 6 
M HCl, to facilitate stripping of CO2, which was trapped in the second tube. 
14C activity 
remaining in the first tube was referred to as nonstrippable residue (NSR).  The percent 
distribution of 14C, including losses, was calculated as described elsewhere (19). 
 The distribution of 14C in NSR was evaluated by injecting filtered samples (200 
µL) onto a WATERS high performance liquid chromatograph (HPLC) using 0.01 N 
H2SO4 as the eluant and an Aminex® HPX-87H column (300 mm x 7.8 mm) for 
separation of organic acids.  Eluent samples were collected in LSC according to the 
elution times for lactate, formate, acetate, propionate, ethanol, isobutyrate and butyrate 
(based on the retention times of authentic material).     
3.3.6 Denaturing gradient gel electrophoresis (DGGE) and protein analysis  
DNA was extracted from cultures using an UltraClean® Microbial DNA isolation 
kit (MO BIO Laboratories, Inc.). A segment of the 16S rRNA gene of the bacteria 
domain was amplified with primer 1055F and 1406R with a 40 base GC clamp (18). A 
touchdown PCR program (18) was adapted as follows: an initial denaturation step at 94 
°C for 5 min; 10 cycles at 94 °C for 1 min, 65 °C for 1 min (touch down -1°C/cycle), 72 
°C for 3 min; 20 more cycles at 94 °C for 1 min, 55 °C for 1 min, 72 °C for 3 min, with a 
final extension step at 72 °C for 10 min. The amplified rDNA was analyzed by DGGE 
(74).  Bands of DNA excised from the DGGE gel were soaked in 1× SB buffer for a 
week, re-amplified by PCR, purified with a QIAquick PCR purification kit (QIAGEN 
Sciences), then submitted to MWG-Biotech, Inc. (Huntsville, AL) for sequencing. 
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Species were identified by sequence alignment via Basic Local Alignment Search Tool 
(BLAST). 
Protein was measured with a BCA™ protein assay kit (Pierce Chemical Company) 
following the manufacturer’s enhanced protocol after lysing the cells (15). 
3.3.7 Identification of isolates   
DNA was isolated from the two pure cultures using the same kit described above.  
DNA was quantified spectrophotometrically and 30 µg was used as a template.  The 
small subunit 16S rRNA gene was amplified using primers 8F and 1492R (26, 84) using 
the following PCR conditions: one cycle at 95°C, 3 min; 55°C, 1 min; 72°C, 2 min; 35 
cycles at 95°C, 45 sec; 55°C, 45 sec; 72°C, 2 min; and one cycle of 72°C for 15 min.  
The resulting PCR product was cloned using the TOPO-TA cloning system (Invitrogen, 
Inc, Carlsbad, CA).  Recombinants were selected for using 50 µg/mL kanamycin and 20 
µg/mL X-gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside).  Recombinant 
plasmids were isolated using the alkaline mini-preparation and subsequently digested 
with EcoRI.  Plasmids with full length inserts were submitted to the Clemson University 
Genomics Institute for DNA sequence analysis.  16S rRNA gene s quences of the two 
isolates were identified via BLAST (2) and deposited in the GenBank database under 
accession numbers FJ745299 and FJ745300. 
3.4 Results 
3.4.1 Development of DHM-1  
 An enrichment culture capable of transforming CF was acclimated to increasing 
concentrations (Figure 3-1a).  CF transformation rates increased throughout the 
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enrichment process and reached an average rate of 6.6 mg/L/day with the final dose of 
500 mg/L. Accumulation of reductive dechlorination products, i.e., DCM and CM never 
exceeded 2 and 1 mg/L, respectively, and no methane was produced. With a subsequent 
1% transfer, the resulting culture biotransformed 500 mg/L of CF at an verage rate of 17 
mg/L/d (Figure 3-1b). This rate increased somewhat through repeated tr nsfers, reaching 
a maximum of 22 mg/L/d.  Formation of DCM and CM continued to be negligible.  
3.4.2 Product distribution from [14C]CF   
 The principle products from [14C]CF transformation by DHM-1 were CO 
(67±2%), NSR (15±0.1%) and CO2 (2.7±0.7%).  All of the other potential products, 
including DCM, CM, and methane, were negligible (consistent with GC headspace 
analyses). HPLC fractionation revealed that the NSR consisted mainly of formate 
(36±3%) and propionate (13±1%).  The total loss of 14C-labeled material during the 26 
day incubation period was 13% (±0.8 %).   
3.4.3 Growth of DHM-1 while transforming CF   
 Significant growth of DHM-1 (based on an increase in protein concentration) 
occurred in the presence of high concentrations of CF (Figure 3-2a). The initial protein 
concentration in all treatments was approximately 5 µg/mL.  As expected, corn syrup was 
required for the growth of DHM-1; no significant growth occurred without it (i.e., in the 
treatments with the culture and MSM plus “CF only”; “B12 only”; and the “blank,” i.e., 
MSM only).  Among the four treatments with corn syrup added, protein levels increased 
to approximately 100 µg/mL.  The presence of CF did not have an inhibitory effect on 
protein yield when B12 was present and CF was transformed (Figure 3-2b, “CF+B12+CS”).  
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However, the presence of CF without B12 did have a modest inhibitory effect on protein 
yield (Figure 3-2a, “CF+CS”) and CF transformation was minor (Figure 3-2b, “CF+CS”).  
Addition of B12 with corn syrup (without CF) did not increase the protein yield above 
corn syrup alone (also without CF) (Figure 3-2a, “B12+CS” versus “CS”).  No significant 
transformation of CF occurred in the live treatment with only CF added (Figure 3-2b, 
“CF only”) or in the control with MSM and B12 but no DHM-1 (Figure 3-2b, “MC+B12”).  
These results indicate that CF removal was a biotic process, rquiring the presence of 
DHM-1, corn syrup and B12.    
 Based on monitoring of protein concentration over time, most of the growth f 
DHM-1 occurred when CF levels were in the 400 to 500 mg/L range (Fiure 3-3).  Only 
after growth reached a plateau (in this case with only one dose of 960 mg COD/L corn 
syrup on day 0) did most of the CF undergo transformation.  A similar growth pattern for 
DHM-1 was observed with only corn syrup added (i.e., without CF and B12) (Appendix 
B.1). Since the protein concentration was 60 µg/mL for most of the time period when CF 
was transformed, the average overall transformation rate of 22 mg/L/d can be expressed 
as 0.37 mg CF/mg protein/d.  
3.4.4 Importance of sulfide to CF transformation   
 The contribution of sulfide to CF transformation by the DHM-1 enrichment 
culture was examined by replacing sulfide in the MSM with an equimolar amount of 
sodium sulfate (0.5 mM) (Appendix B.2).  Without sulfide present, the colorof the MSM 
was blue (based on the resazurin), indicating the Eh was above -110 mV.  Approximately 
12 h after inoculation, the color of the medium became clear (based on the color change 
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in the resazurin) and turbidity in the bottles indicated growth had occurred.  Nevertheless, 
the rate of CF transformation was considerably slower than controls with the standard 
MSM containing sulfide, i.e., approximately 5.5 mg/L/d versus 22 mg/L/d.  In an effort to 
restore the rate of CF transformation, the bottles were reinoculuated with the same 
amount of DHM-1 on days 18 and 26 and corn syrup was added on day 18.  The rate of 
CF transformation did not improve.  On day 48 more corn syrup was added an  on day 
50, sulfide was added so that the aqueous concentration was the same as in MSM, i.e., 0.5 
mM.  The rate of CF transformation increased significantly to 16 mg/L/d, similar to the 
performance of DHM-1 in sulfide-reduced MSM.   
3.4.5 DGGE Analysis of DHM-1  
 During development of the DHM-1 culture, DNA from the fourth transfer was 
extracted and analyzed by DGGE.  A total of six bands were resolved (Figure 3-4, lane 1). 
Sequencing of bands B, C, D and E were most similar to En erobacter spp. (95-99%), 
while band F was most similar to a Propionibacteriaceae sp. (98%).  The latter was no 
longer detectable by the sixth transfer (Figure 3-4, lane 2). The intensity of Band A, 
which was not sequenced, decreased to a nearly undetectable level in the te th transfer 
version of the culture. The four bands that remained were all associted with 
Enterobacter spp., indicating that they are the ones responsible for CF biotransformation.  
3.4.6 Isolate identification and CF transformation  
 The two strains isolated from DHM-1 are Gram negative, motile rods.  The faster 
growing isolate was designated strain DHM-1B and the slower growing one was 
designated strain DHM-1T.  Based on their 16S rRNA gene sequences, the closest match 
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for both strains is to Pantoea (Enterobacter) spp.  Strains DHM-1B and DHM-1T align 
most closely with Pantoea sp. Nj-40 (100%) and Enterobacter spp. (up to 99%), 
respectively.  When evaluated by DGGE, the isolates exhibited multiple bands (Figure 3-
4, lanes 4 and 5).  The presence of multiple bands for pure cultures during DGGE has 
been reported previously (6).  
Strains DHM-1B and DHM-1T retained the ability to transform high 
concentrations of CF.  After inoculating them in MSM, there was a lag of 10 to 20 days 
before the onset of CF transformation.  However, with subsequent transfers (5% v/v), the 
rate of CF transformation was similar and occasionally faster than the DHM-1 
enrichment culture (Figure 3-5), reaching as high as 26 mg/L/d.  As with DHM-1, 
transformation of 500 mg/L of CF by both isolates yielded negligible amounts of DCM 
and CM (i.e., less than 1.5 mg/L and 0.03 mg/L, respectively) and no methane.  In 
addition, growth of both strains was not inhibited by the presence and/or transformation 
of CF, as was shown with DHM-1 (Figure 3-2a).     
3.5 Discussion 
 DHM-1 is the first enrichment culture reported that is capable of biotransforming 
high concentrations of CF, e.g., at least as high as 500 mg/L. The two Pantoea spp. 
isolated from DHM-1 are the first strains reported that possess this dechlorination 
capability. Growth on corn syrup is required along with the presence of a catalytic level 
of vitamin B12, which appears to direct the transformation pathway away from reductive 
dechlorination and towards net hydrolysis to CO, oxidation to CO2, and incorporation 
into organic acids.  A similar role for B12 was reported by Hashsham and Freedman for 
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transformation of high concentrations of CT by fructose-grown A. woodii (47).  Becker 
and Freedman (12) also observed the need for B12 during transformation of CF by a 
DCM-grown culture, yielding similar end products as DHM-1.    
 The ability of the DHM-1 enrichment culture and strains DHM-1B and DHM-1T 
to grow on corn syrup in spite of the presence of high concentrations of CF is especially 
noteworthy, given the toxicity of CF to most anaerobic microbes.  With cometabolic 
processes, it is common for relatively low concentrations of the nongrowth substrates to 
inhibit growth on the primary substrate.  For example, CF was found to be inhibitory to 
the growth of an anaerobic culture that cometabolizes CF (12).  Less than 10 µM 1,1-
DCE and cis-DCE, or 100 µM of CF, DCM, vinyl chloride, and trichloroethylene  is 
inhibitory to the growth of most types of methanotrophs (3, 45, 52). This is partly why 
cometabolic processes are more difficult to engineer than metabolic processes, i.e., 
growth on the primary substrate is often not feasible in the presenc  of the non-growth 
substrate, due to competitive inhibition of a shared enzyme (e.g., an oxygenase) and/or 
product toxicity.  The ability of the cultures obtained during this study offers a potentially 
significant advantage for in situ application, i.e., only a low initial dose of culture may be 
needed since the microbes are capable of growth on corn syrup in the presence of high 
concentrations of CF.   
 Pantoea (or Enterobacter) is not a genus commonly associated with 
biodegradation of halogenated compounds.  Nevertheless, a few strains with this ability 
have been reported, including some Enterobacter strains that dechlorinate 
polychlorinated biphenyls (1), DDT (13), toxaphene (60) and tetrachloroethene (80). In 
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addition, it appears that tolerance of high concentrations of halogenated compounds may 
be a characteristic of Enterobacter species. For example, strain MS-1, which is closely 
related to E. agglomerans, is able to grow in the presence of tetrachloroethene at 
concentrations above saturation (2-10 mM) (80).  Likewise, strain D-1, which is closely 
related E. colacae, is able to grow in the presence of toxaphene at concentrations ab ve
saturation (3-96 mg/L) (60).   
  Enterobacter are facultative microbes. This makes the DHM-1 enrichment 
culture and the two isolates easier to handle than obligate anaerobic cultures, especially 
for field application.  The ability of the isolates to transform CF was retained even after 
repeated streaking on TSA and incubation under aerobic conditions during the cultur  
isolation process.  The cultures also retained their CF-transformati n ability after at least 
24 h exposure to air and then returning them to anaerobic MSM (Appendix B.3).  It may, 
therefore, be possible to apply DHM-1 in the field even before the in-situ redox 
conditions are sufficiently reducing to achieve CF transformation.  Fermentative growth 
of DHM-1 on corn syrup causes the redox level of the surrounding environment to 
decrease below -110 mV within several days, thereby creating co ditions that are 
favorable for CF transformation.  This is similar to the ability of strain MS-1 to grow in 
the presence of PCE under conditions that are too oxidized to support reductiv  
dechlorination of PCE; however, once the redox conditions become more reducing, 
chlororespiration of PCE to cis-1,2-dichloroethene by Strain MS-1 commences (80). 
 Egli et al. (27) have noted that anaerobic dechlorination of chlorinated methanes 
is often associated with microbes that possess the acetyl-CoA pathway, which involves 
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coenzyme B12 as a carrier for one carbon methyl groups.  The presumed benefit of adding 
supplemental B12 is to mitigate the toxic effects of the chlorinated compounds on 
coenzyme B12 and carbon monoxide dehydrogenase (47). However, Enterobacter spp. 
ferment sugars via a mixed acid pathway that does not involve the acetyl-CoA pathway 
and has no dependence on B12 (53, 69), so it is less clear what role B12 plays in 
facilitating CF cometabolism by these microbes.  However, some genera of 
Enterobacteriaceae use a B12-dependent dehydratase to mitigate toxicity during 
metabolism of 1,2-propanediol and 1,2-ethanediol (87).  The reactions take plac  in 
microcompartments that provide protection from DNA and cellular damage by a reactive 
metabolic intermediate (76).  B12-dependent reductive dehalogenases have been purified 
from several anaerobes mediating reductive dechlorination of chloroethenes (10). 
However, transformation of CF by DHM-1 and strains DHM-1T and DHM-1B proceeds 
mainly via net hydrolysis to CO, not via reductive dechlorination to DCM, CM, or 
methane.  It is not yet known if a B12-dependent dehalogenase homologous to reductive 
dehalogenases is involved in the hydrolytic pathway for CF transformation, or, more 
generally, what role B12 plays in CF transformation by the isolates obtained in this study.  
 In addition to catalytic levels of B12, transformation of CF by DHM-1 appears to 
require sulfide.  The MSM used in this study contains 0.5 mM; whether or not lower or 
higher concentrations affect the rate of CF transformation is not yet known.  The role of 
sulfide (0.5 mM) in CT transformation by Pseudomonas stutzeri KC via a bacterial 
transition metal chelator has been demonstrated, with the undesirable effect of increased 
production of CS2 (65).  CS2 formation during transformation of CF by DHM-1 is not a 
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concern.  However, maintaining a low level of sulfide in groundwater poses some 
practical challenges for in situ remediation, including a potentially high demand for 
sulfides by the aquifer soil. Substitution of sulfide with another reluctant such as 
dithionate is worthy of further investigation, including the effect on the transformation 
rate of CF by DHM-1.  
 The appearance of multiple bands on the DGGE gel for DHM-1B and DHM-1T 
likely represent multiple copies of the 16S rRNA gene. Enterobacter are known to 
possess multiple copies of the rRNA operon. For example, two species r portedly have 
seven copies of operon (54).  
 It is not yet known what properties of DHM-1 and strains DHM-1B and DHM-1T 
enable them to grow on corn syrup in the presence of such high concentrations of CF as 
well as transform the CF.  One possibility is the presence of microcompartments, the 
presence of which in several types of fermentative microbes has been linked to B12-
dependent degradation of 1,2-propanediol (76).  The microcompartments in this 
environment protect the cells from damage from a toxic metabolic intermediate.  
Alterations to membrane fluidity may also play a role in the ability of the cultures in this 
study to tolerate high concentrations of CF. Alterations in membrane structure, 
particularly in fatty-acids composition, phospholipid headgroups, and protein content, is a 
principal adaptive mechanism used by bacteria to resist the toxic effect of solvents (50).  
 The use of cultures in bioaugmentation is restricted to those that do not contain 
human pathogens.  Some species of Enterobacter (also known as Pantoea) are known to 
behave as pathogens (17, 78).  However, the pathogenicity of DHM-1, DHM-1T and 
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DHM-1B is not yet known.  If pathogenicity is not a concern, then these microbes show 
significant promise for in situ bioaugmentation at sites with high concentrations of 
halomethanes, based on their ability to grow in the presence of CF using an inexpensive 
substrate (i.e., corn syrup) and transform CF with the aid of catalytic levels of B12.  The 
predominant transformation products formed (CO, CO2, and organic acids) are 






























Figure 3-1 Increase in the rate of CF transformation during initial development of 
the DHM-1 enrichment culture (a) and following a transfer (1% v/v) in MSM (b). 

























































































Figure 3-2 Effect of CF on growth of DHM-1 based on protein yields after 35-39 
days of incubation (a); and associated CF transformation in the three live 
treatments and media control with B12 but no culture (MC+B12) (b); blank=live 
culture + MSM only; CS=corn syrup; error bars are the standard deviation for 
duplicate measurements from duplicate bottles.  Corn syrup was added on days 0 

























































































Figure 3-3 Growth of DHM-1 while transforming CF. The average of duplicate 
bottles are shown. Error bars are the standard deviation for duplicate 















































Figure 3-4 Variation of microbial structure of DHM-1 along with transfers and 
comparison among the mixed culture and its isolates by DGGE. Lane 1, 2, and 3 are 
the fourth, sixth, and tenth transfers of DHM-1, respectively; lane 4 is strain DHM-
1B, lane 5 is strain DHM-1T. 

















Figure 3-5 CF transformation by the two Pantoea strains. Formation of DCM and 
CM was minor (< 1% of CF transformed). Results are the average of duplicate 




























4. EVALUATION OF CAPACITY OF DHM-1 FOR TRANSFORMING HIGH 
CONCENTRATIONS OF HALOMETHANES IN MEDIA AND MICROCOSM 
AND COMPARISON TO A COMMERCIAL CULTURE 
4.1 Abstract  
 Following the development and characterization of DHM-1, a natural aquifer 
derived enrichment culture capable of transforming over 500 mg/L chloroform (CF), the 
capacity of DHM-1 for biotransforming high concentrations of halogenated m thanes 
was explored. With addition of catalytic amounts of vitamin B12, DHM-1 can readily 
transform at least 2000 mg/L CF. Furthermore, DHM-1 is active on transformation of 
carbon tetrachloride (CT) and trichlorofluoromethane (CFC-11), too. Complete 
transformation of 11 mg/L CT, 24 mg/L CFC-11 and 504 mg/L CF was achieved in less 
than four months by DHM-1 in mineral salts medium. CO, CO2 and organic acids are the 
prevailing end products of transformation of CT and CF, indicating hydrolytic reactions 
instead of reductive dechlorination are the dominant pathways. This study also 
demonstrated the capability of SDC-9, a commercially available mixed culture, to 
transform high concentrations of halomethanes. DHM-1, has an advantage over SDC-9 in 
terms of the rate of CF transformation, while SDC-9 exhibited a higher rate on CFC-11. 
A microcosm study further demonstrated the use of these two cultures for 
bioaugmentation to enhance in situ bioremediation of groundwater contaminated by high 





 In spite of major recent advances in bioremediation of groundwater, efficient in 
situ bioremediation strategies to treat groundwater contaminated with high concentrations 
of halogenated methanes such as CT, CF, and CFC-11 are still lacking.  On the 2007 
CERCLA Priority List of Hazardous Substances, CF ranks eleventh, the third highest 
among chlorinated organics, after vinyl chloride and polychlorinated biphenyls (8).  This 
is a reflection of how often CF is detected in groundwater and its high level of toxicity.  
Although not ranked as highly, CT is also on the list, and CFC-11 is often a co-
contaminant with CT and CF.  Among these compounds, CF is often the focal point for 
evaluating the feasibility of bioremediation because of its high toxicity to most obligate 
anaerobic prokaryotes. For instance, tetrachloroethene dechlorination by a mixed 
dechlorinating anaerobic culture was completely inhibited by only 1 mg/L of CF (73). 
Inhibition of reductive dechlorination of chloroethenes by CF is a major concern for sites 
co-contaminated with CF, and can only be overcome by removing the CF first (73).   
 Although bioaugmentation is rapidly maturing as a technology for treatment of 
chlorinated ethenes (28), there is comparably little information for halogenated methanes.  
Information was found for only one commercially available culture, SDC-9, that is being 
marketed for its ability to transform CT and CF (28).  However, the characteristics of 
SDC-9 in terms of transformation rates and products formed during halomethane 
transformation have not been reported.    
 The results presented in Chapter 2 demonstrated that bioaugmentation is a 
technically feasible strategy for sites contaminated with high concentrations of 
 
 81
halomethanes.  Of the three enrichment cultures described in Chapter 2, th  fermentative 
culture that grows on corn syrup exhibited the most promise, especially in terms of its 
ability to cometabolize CF.  Corn syrup was the most effective substrate tested and 
addition of catalytic levels of vitamin B12 was essential for sustaining a rapid rate of 
transformation to environmentally benign products.   
 In Chapter 3, the characteristics of the DHM-1 enrichment culture wer  further 
explored, based mainly on its ability to cometabolize CF.  Two isolates (strains DHM-1B 
and DHM-1T) obtained from DHM-1 were also evaluated in terms of their ability to 
cometabolize CF.  The objectives of this study were 1) to furher characterize DHM-1 in 
terms of its ability to cometabolize CT and CFC-11, alone and in mixtures that included 
CF, and the tolerance of DHM-1 to concentrations of CF up to 4,000 mg/L; and 2) to 
compare DHM-1 to SDC-9 with respect to their transformation rates for CT, CFC-11 and 
CF; the distribution of products formed using [14C]CT and [14C]CF; and the performance 
of these cultures in microcosms.  The microcosms were similar to the ones described in 
Chapter 2, although the focus was on bioaugmentation and the effect of vari us 
amendments on performance of DHM-1 and SDC-9.   
4.3 Materials and methods 
4.3.1 Chemicals, radioisotopes, enrichment cultures and culture media 
 CT (99.9%, Sigma-Aldrich), CF (99.7%, Shelton Scientific), dichloromethane 
(DCM; 99.9%, AlliedSignal), CFC-11 (99%, Aldrich), and CS2 (100%, J.T.Baker) were 
obtained as neat liquids.  Chloromethane (CM; 99%, Praxair), dichlorofluoromethane 
(HCFC-21; 99%, SynQuest Labs), chlorofluoromethane (HCFC-31; 99%, SynQuest 
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Labs), and methane (99.99%, Matheson) were obtained as neat gases. Neat 14C-labeled 
CT (1.0 mCi/mmol) and CF (0.5 mCi/mmol) were purchased from American 
Radiolabeled Chemicals, Inc.  Stock solutions of [14C]CT and [14C]CF were prepared in 
distilled deionized water at concentrations of approximately 107 disintegrations per 
minute (dpm) per mL.  Sodium lactate (60% syrup, EM Science) and corn syrup (regular 
type, Sweetener Products Company) were used as electron donors.  The chemical oxygen 
demand (COD) for corn syrup was calculated based on its presumed composition, i.e., 
C6H12O6.   Cyanocobalamin (i.e., vitamin B12, USP grade) was obtained from Research 
Organics, Inc.   
 Two types of enrichment cultures were used in this study, DHM-1 and SDC-9.  
The development of DHM-1 is described in Chapter 3, including its ability to 
biotransform up to 500 mg/L of CF to nontoxic products.  Corn syrup serves as the 
growth substrate. SDC-9 is a commercially available culture marketed for use in 
bioremediation of chlorinated ethenes and ethanes.   
 The mineral salts medium (MSM) used to grow DHM-1 is the same as that 
described in Chapter 3.  The revised anaerobic mineral medium (RAMM) used for SDC-
9 was prepared as previously described (81), with the following changes.  Yeast extract 
was added (0.05 g/L) and the concentration of sodium sulfide was decreas d to 0.12 g/L 
Na2S⋅9H2O (i.e., 0.5 mM sulfide), so that the MSM and RAMM had the same 
concentrations of both of these components.     
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4.3.2 Transformation experiments with the enrichment cultures  
 Transformation experiments employing DHM-1 and SDC-9 were performed with 
the individual halomethanes (approximately 15 mg/L CT, 26 mg/L CFC-11 and 500 
mg/L CF).   The same initial protein concentrations were used for both cultures 
(approximately 5 µg/mL). Treatments with and without vitamin B12 (3% molar ratio) 
were prepared in 160 mL serum bottles with 100 mL of MSM or RAMM and 60 mL of 
headspace, in an anaerobic chamber (Coy laboratory Products, Inc.) containing an 
atmosphere of approximately 98% N2 and 2% H2. The initial dose of substrate provided 
was approximately 960 mg/L as COD. After purging the headspace with 30% CO2/70% 
N2 for 1 min, the bottles were sealed with 20-mm Teflon-faced red rubber septa and 
aluminum crimp caps. Halomethanes were then added using neat compounds. Media 
controls (no culture present) with and without B12 for each halomethane were prepared in 
MSM and RAMM.  
 In the bottles that received CT and CF, [14C]CT and [14C]CF were also added to 
provide an initial 14C activity of 106 dpm/bottle.  The labeled compounds were added 
prior to adding the neat compounds.  The gas chromatographic method described in 
Chapter 3 was used to add the labeled compounds, to minimize the introduction of 14C 
impurities in aqueous stocks.   
 The bottles were quiescently incubated in an inverted position in boxes at room 
temperature (22 °C) in the anaerobic chamber. pH was monitored weekly and maintained 
between 6.7-7.7. A second dose of substrate was added when the pH stopped decreasing, 
signifying a cessation in substrate utilization, as described in Chapter 3. 
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 The ability of the DHM-1 culture to transform two-component mixtures of the 
halomethanes was examined, as well as transformation when the three halomethanes 
were present at the same time.  For the two-component experiments, a single dose of B12 
was provided at the start (3% molar ratio of the total halomethanes dded).  When all of 
the halomethanes were present, the first dose of B12 was made based on the molar amount 
of CT (i.e., 3 mole percent).  When CT transformation was nearly complete, a second 
dose of B12 was made based on the molar amount of CFC-11 added, and when CFC-11 
was nearly consumed, a third dose was added based on the CF added.  Along with the 
second dose of B12, a second addition of DHM-1 was made (adding another 5 µg/mL of 
culture), since preliminary tests suggested that the culture’s activity on CFC-11 and CF 
was inhibited after completing transformation of CT, presumably because the CT 
transformation pathway may involve some inhibitory intermediates, e.g., thiophosgene 
(65).  In addition to media controls with B12 present, water controls (WC) and autoclaved 
controls (AC) were prepared as part of the experiment with all three halomethanes 
present.  WC consisted of 100 mL of distilled deionized water; AC consisted of bottles 
that were inoculated with DHM-1 in MSM and then autoclaved for 1 h, after which the 
neat halomethanes were added.     
4.3.3 Microcosm evaluation of bioaugmentation with DHM-1 and SDC-9 
 The effectiveness of the two enrichment cultures for use in bioaugmentation was 
compared in a microcosm study. In addition to bioaugmentation, the other treatments 
included as-is conditions (no substrate or B12 added), biostimulation with corn syrup, and 
biostimulation with corn syrup + B12.  All treatments were prepared in triplicate.  Soil 
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from the high concentration area of the industrial site described in Chapter 2 was used.  
Five types of liquid were used, depending on the type of treatment (Table 4-1).  All were 
prepared with a sample of municipal tap water obtained from the industrial si e.  Use of 
buffered municipal water was designed to simulate extraction of gr undwater and 
injection of municipal water, to adjust the in situ pH without accumulating precipitates 
(column B in Table 4-1).  To determine if bioaugmentation requires the presence of the 
chemicals found in the MSM and RAMM, the respective media were prepared using the 
municipal water (column FD for DHM-1 and FS for SDC-9 in Table 4-1).  However, the 
municipal water was not autoclaved or deoxygenated prior to adding the chemicals, as 
was done with the media.  In addition, sulfide for FD and FS treatments was not added 
until the first bioaugmentation event.  Considering the potential difficulties of adding 
sulfide in situ, two other types of media were prepared using municipal water wi h an 
equimolar amount of sulfate replacing the sulfide (column FD' for DHM-1 and FS' for 
SDC-9 in Table 4-1).  The intent was for sulfate to be microbially reduced to sulfide in 
the microcosms.  Resazurin was added (1 mg/L) to all bottles to serve as a redox 
indicator. 
 The microcosms were prepared in 160 mL serum bottles with 20 g of soil and 50 
mL of liquid (Table 4-1) inside an anaerobic chamber. After purging the headspace with 
high purity N2 for 1 min, the microcosms were sealed with 20-mm Teflon-faced red 
rubber septa and aluminum crimp caps.  The microcosms were then placd on a shaker 
table for one hour to facilitate obtaining equilibrium between the soil and liquid phase.  
Liquid samples (0.2 mL) were removed to measure sulfate and confirm that the initial pH 
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was between 7.3 and 7.6.  CT, CFC-11, and CT were then added using neat liquids to 
achieve initial concentrations of 10, 26, and 500 mg/L, respectively. Due to the high 
vapor pressure of CFC-11, it was necessary to cool the neat material nd the syringe used 
to add it to 4ºC. Finally, an initial dose of corn syrup or lactate was made (720 mg/L 
COD) to the appropriate treatments (Table 4-1).  The microcosms were quiescently 
stored in an inverted position in boxes at room temperature in the anaerobic chamber.   
 Vitamin B12 was added using the same dosing strategy described above for the 
experiment with DHM-1 in MSM with CT, CFC-11, and CF present at the same time.  
However, the first dose of B12 (0.31 µmol/bottle) was not made until the liquid reached 
an Eh of less than -110 mV, based on the color change of the resazurin.  The second dose 
(2.42 µmol/bottle) was made when consumption of CT was nearly complete and the third 
dose (7.94 µmol/bottle) was made when CFC-11 was nearly gone.  
 The first bioaugmentation dose was made at the same time or shortly after the first 
addition of B12, i.e., after low redox conditions had developed.  The volume of 
enrichment culture added was adjusted so that the resulting protein cncentration in the 
microcosms was 5 µg/mL (i.e., the same concentration used to inoculate the cultures in 
media alone).  A second dose of bioaugmentation culture was made once CT was nearly 
consumed.  Subsequent additions were made in an attempt to achieve the same rates in 
the microcosms that were observed with DHM-1 in MSM.   
 pH was monitored approximately once per month and was maintained in the 
range of 6.7-7.5. Additional amounts of corn syrup or lactate (720 mg COD/L per dose) 
were provided when the pH stopped decreasing, as described in Chapter 3.  
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4.3.4 Analytical methods and 14C distribution 
 The amount of volatile organic compounds (CT, CFC-11, CF, DCM, CM, HCFC-
21, HCFC-31, methane and CS2) present in serum bottles was determined based on 
analysis of headspace samples using gas chromatography.  For the microcosm 
experiments, the same method described in Chapter 2 was used and for the 
transformation experiments, the same method described in Chapter 3 was used.  
Compounds were separated and quantified using a Hewlett Packard 5890 Series II gas 
chromatograph (GC) equipped with a flame ionization detector and a 2.44 m × u3.175 
mm column packed with 1% SP-1000 on 60/80 Carbopack B (Supelco).  A GC response 
factor for each volatile organic compound was measured to relate the otal mass of the 
compound to the GC peak area (38). Previously reported values for Hc at 23°C was used 
(7, 38, 77).  The detection limit of this method was lower than the maximum contaminant 
level for each of the chlorinated compounds. 
 Sulfate was measured on a Dionex AS50 ion chromatography system equipped 
with a CD25 Conductivity detector and a Dionex guard column (AG9-HC, 4 mm x 50 
mm) followed by an IonPac® AS9-HC anion-exchange column (4 mm x 250 mm).  
Eluant (9 mM Na2CO3) was delivered at 1.0 mL per min. Protein concentration was 
measured with a BCATM protein assay kit (Pierce Chemical Company) by following the 
manufacturer’s enhanced protocol after lysing the cells (15).  
 The amount of 14C activity and its distribution were quantified using the same 
methods described in Chapter 3.  The total 14C activity remaining in bottles was measured 
by counting 0.5 mL headspace and 0.1 mL liquid phase sample. The distribution of 14C 
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was determined through headspace and liquid phase analyses.  Volatile 14C-labeled 
compounds were analyzed with headspace samples and a GC-combustion technique (35).  
14CO2 and 
14C-labeled nonvolatile compounds were determined through liquid phase 
analyses (33).  
4.3.5 Sulfide demand test and dissolved sulfide measurement 
 Dissolved sulfide was analyzed following the methylene blue colorimet ic assay 
in Standard Methods (40).  To investigate th  sulfide demand of the soil used to prepare 
the microcosms, bottles in duplicate were prepared with 20 g of soil and 50 mL municipal 
water (1 mg/L resazurin added) inside the anaerobic chamber. After purging the 
headspace with high purity N2 for 1 min, sulfide was added (2, 4, 8, 12, and 16 mM).  
The bottles were incubated in the anaerobic chamber and the remaining dissolved sulfide 
was measured after 7 and 21 days of incubation.  
4.4 Results 
4.4.1 Biotransformation of CT, CFC-11 and CF by DHM-1 
 When provided with corn syrup and B12, DHM-1 readily transformed the three 
halomethanes, although the culture was developed to transform CF and was not 
previously acclimated to CT or CFC-11. Transformation of approximately 16 mg/L CT 
(i.e., 18 µmol/bottle) was completed in 14 days (Figure 4-1a). Up to 1.5 mg/L (2.9 
µmol/bottle) of CS2 accumulated, accounting for 16% of the CT transformed, indicating 
the substitutive pathway was involved in CT transformation. Formation of reductive 
dechlorination products (i.e., CF, DCM and CM) was negligible. Over a 14 day 
incubation period, transformation of CT was not observed in the live control (i.e., DHM-
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1 with corn syrup but without B12), although some removal (20%) occurred in the media 
+ B12 control.  No transformation of CT occurred in a control with media without B12 
( Appendix C.1), indicating that B12 contributed to abiotic transformation of CT.     
 Biotransformation of CFC-11 started after a lag phase of approximately 10 days 
(Figure 4-1b). Then, 24 mg/L (56 µmol/bottle) of CFC-11 was completely transformed 
by day 48. Approximately equal amounts of HCFC-21 and CS2 (i.e., approximately 3 
µmol/bottle each) accumulated, accounting for 11% of the total CFC-11 transformed, 
while formation of HCFC-31 was negligible. There was only a minor amount of CFC-11 
transformation in the live control (i.e., DHM-1 with corn syrup but without B12) and 
media + B12 control, proving the CFC-11 transformation was biotic and required a 
catalytic amount of B12.  No transformation of CFC-11 occurred in a control with media 
without B12 (Appendix C.1). 
 DHM-1 transformed 513 mg/L CF (i.e., 464 µmol/bottle) in as short as 23 days 
including a 5-day lag phase (Figure 4-1c), or an average rate of 22 mg/L/d.  This is 
consistent with previously reported rates for DHM-1 (Chapter 3).  Only 0.8 mg/L DCM 
(1 µmol/bottle) and 0.9 mg/L of CS2 (1.8 µmol/bottle) accumulated, accounting for 0.6% 
of the CF transformed. In the live control (i.e., DHM-1 with corn syrup b t without B12) 
and media + B12 control, there was no transformation of CF. No transformation of CF 
occurred in a control with media without B12 (Appendix C.1), 
 In the vicinity of a source zone of CF that contains nonaqueous phase liquid, the 
aqueous phase concentration of CF will be higher than 500 mg/L.  Experiments were 
conducted to determine the ability of DHM-1 to transform higher concentrations.  As 
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shown in Figure 4-2, an initial concentration of CF of approximately 1000 mg/L (i.e., 900 
µmol/bottle) was transformed by DHM-1 in 85 days and 2000 mg/L (i.e., 1800 
µmol/bottle) was consumed in 180 days. Accumulation of DCM and CS2 was negligible, 
i.e., less than 0.5 and 1.0 µmol/bottle, respectively. WC results proved that iffusive loss 
of CF over the incubation period was minor.  The activity of DHM-1 on CF ceased when 
the initial CF concentration was 4000 mg/L (i.e., 3.6 mmol/bottle), which is 
approximately 50% of saturation of CF in water.  In spite of these high initial 
concentrations of CF, growth of DHM-1 on corn syrup was not adversely aff cted. An 
increase of 94, 102 and 133 µg/mL of protein on approximately 1920 mg COD/L corn 
syrup was detected at the end of the incubation period (Figure 4-2), for initial CF 
concentrations of 1000, 2000 and 4000 mg/L, respectively.  This level of growth is 
similar to previously reported values for DHM-1 in the presence and absence of CF at 
500 mg/L (Chapter 3). Although growth of DHM-1 in the presence of CT and CFC-11 
was not measured in terms of protein levels, an increase in the turbidity of the culture was 
observed, suggesting that DHM-1 also grows on corn syrup in the presence of CT and 
CFC-11. 
4.4.2 Biotransformation of halomethane mixtures by DHM-1  
 In the presence of 12 mg/L CT (13 µmol/bottle) and 512 mg/L CF (463 
µmol/bottle), DHM-1 biotransformed both halomethanes simultaneously (Figure 4-3a), 
with no apparent effect of CT on CF or vice versa (i.e., comparing Figure 4-1 and Figure 
4-3).  Transformation of CT and CF was complete in 10 and 33 days, respectively. A 
minor amount of CS2 (5.2 µmol/bottle) accumulated, accounting for 1% of the sum of CT 
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and CF transformed.  Formation of DCM (0.6 µmol/bottle) was negligible (Figure 4-3a).    
With a mixture of 23 mg/L CFC-11 (55 µmol/bottle) and 509 mg/L CF (461 µmol/bottle), 
DHM-1 biotransformed the CFC-11 in 29 days, which was somewhat faster than being 
transformed individually (Figure 4-1b). This may indicate that DHM-1 functions better 
on CFC-11 when CF is present.  In contrast, transformation of CF was inhibited by the 
presence of CFC-11; CF transformation did not begin until the concentratio  of CFC-11 
dropped to 6 mg/L (14 µmol/bottle) on day 18, then finished by day 48 (Figure 4-3b). 
Minor amounts of CS2, DCM and HCFC-21 accumulated (4.2, 0.5 and 1.8 µmol/bottle, 
respectively) in comparison to the amount of halomethanes removed (Figure 4-3b). With 
a mixture of 16 mg/L CT (17 µmol/bottle) and 24 mg/L CFC-11 (57 µmol/bottle), CT 
was completely transformed in 10 days, and following a lag phase of approximately 10 
days, CFC-11 was consumed by day 47. These patterns are similar to what occurred with 
the individual compounds (Figure 4-1), indicating no apparent interaction between CT 
and CFC-11.  The combination of CT and CFC-11 resulted in more CS2 accumulation 
(5.8 µmol/bottle) than the other two-component mixtures, accounting for 7.7% of the CT 
and CFC-11 transformed. Formation of HCFC-21 (3.3 µmol/bottle) was also slightly 
higher than in the mixture of CFC-11 and CF, while formation of DCM was negligible 
(Figure 4-3c).  
 When CT, CFC-11, and CF were added at the same time (11, 24, and 500 mg/L, 
respectively), the pattern of transformation was similar to what was observed in the two-
component mixtures.  CT (12 µmol/bottle) transformation was completed first, followed 
by CFC-11 (57 µmol/bottle) and then CF (456 µmol/bottle) (Figure 4-4).  This same 
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order of transformation was observed in a microcosm study with the sam  mixture of 
halomethanes (Chapter 2).  One difference between the live bottles shown in Figure 4-4 
and Figure 4-3 is the pattern of B12 addition.  With the two-component mixtures, B12 was 
added only at the start. With the three-component mixture, the same molar ratio of B12 
was added, although the additions were timed to coincide when transformation of each 
compound began.  CT was removed to below detection by day 10. Transformation of 
CFC-11 accelerated after day 8 and proceeded at a nearly linear rat  through day 75. As 
was observed in the CFC-11 + CF mixture (Figure 4-3b), a high rate of CF 
transformation did not start until transformation of CFC-11 was nearly complete on day 
65 (2.5 mg/L, 6 µmol/bottle). Then, the remaining 462 mg/L CF (418 µmol/bottle) was 
removed by day 112 at a rate comparable to those for single (Figure 4-1c) and two-
component mixtures (Figure 4-3b). Only 2 µmol/bottle CS2 accumulated, accounting for 
0.4% of the halomethanes transformed. Formation of reductive dechlorination products 
(DCM, CM, HCFC-21, HCFC-31) was negligible. 
 In the controls with all three halomethanes present, nearly complete 
transformation of CT occurred by day 113 in the media control and AC, versus no 
significant losses from the WC (Figure 4-4a).  Approximately 33% and 11% of CFC-11 
was removed in the autoclaved and media controls, respectively, whie loss of CFC-11 in 
WC was minor (Figure 4-4b). Losses of CF in all three controls were minor (1.5-3.8%).  
These results demonstrate that transformation of CF was exclusively a biotic process, 
while abiotic processes contributed to transformation of CT and CFC-11.  However, 
transformation of CT and CFC-11 was considerably faster in the pres nc  of live cells, 
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and DHM-1 was able to achieve complete transformation of a mixture of CT, CFC-11 
and CF at high initial concentrations in less than four months in MSM.  
4.4.3 Transformation rates   
 The commercially available bioaugmentation culture SDC-9 also exhibited an 
ability to transform CT (15 mg/L), CFC-11 (25 mg/L), and CF (500 mg/L). The trends 
observed for DHM-1 in Figure 4-1 were similar for SDC-9, although there were some 
differences in the rates.  Both cultures showed the highest transformation rate on CF, i.e., 
over an order of magnitude higher than for CT and CFC-11 (Table 4-2). The average and 
maximum rates for CF transformation by DHM-1 were approximately two times greater 
than for SDC-9.  SDC-9, however, transformed CFC-11 at a higher rat  than DHM-1.  
The average CT transformation rate for DHM-1 was slightly higher than for SDC-9 
although their maximum rates were not statistically different (Student’s t-test, α=0.025).  
 The live control and media control for SDC-9 were different from those used for 
DHM-1, due to the differences in media composition between RAMM and MSM.  
Nevertheless, the SDC-9 controls behaved similarly.  Over the sam length of incubation 
time as the live treatment with SDC-9 (i.e., 21, 33, and 41 days for transformation of CT, 
CFC-11, and CF, respectively), less than 10% transformation of CFC-11 and CF occurred 
in the live control, with 15% loss of CT.  In the media with B12 control, losses of CFC-11 
and CF were minor, while CT decreased by 34%.  This was somewhat hig er than the 
comparable control for DHM-1 (Figure 4-1a), although the incubation time for SDC-9 




4.4.4 14C product distribution   
 14CO and 14CO2 were the dominant products from transformation of [
14C]CT and 
[14C]CF (Table 4-3).  The sum of CO and CO2 accounted for approximately 70% of CT 
and CF transformation by both cultures.  CO2 predominated from CT transformation (i.e., 
over 50%) while CO was predominant from CF transformation, especially by DHM-1. 
Nonstrippable residue (NSR) was the third most significant product.  Only a minor 
amount of CS2 accumulated from CT transformation, and relatively more CS2 was 
generated by SDC-9 than DHM-1 (i.e., 10% vs. 5.2%), consistent with GC results.  High 
performance liquid chromatographic fractionation of the NSR (recov ry efficiencies were 
75±7.5% and 59±3.2% for the NSR formed by DHM-1 and SDC-9, respectively) 
indicated that the main products were formate (35%) and propionate (18%) for DHM-1; 
and formate (21%), acetate (11%), and propionate (9%) for SDC-9.   
4.4.5 Microcosm evaluation of bioaugmentation  
 Redox conditions conducive to halomethane transformation (i.e., Eh<-110 mV) 
were established within one week in all treatments that receiv d corn syrup and media-
augmented water (i.e., FD’ or FD in Table 4-1), while it took 15 days for the microcosms 
prepared with buffered water (i.e., B), 25 days for the lactate-am nded SDC-9 
microcosms that received media-augmented water (i.e., FS’ or FS), and 50 days for 
microcosms with only buffered water (i.e., B). This contrast betwen corn syrup and 
lactate is consistent with that observed in the previously reported microcosm study for the 
same site (Chapter 2). As a result, the first dose of bioaugmentation of DHM-1 was 
implemented on day 15, while bioaugmentation of SDC-9 was not done until day 51. 
 
 95
 The initial sulfate concentration in microcosms was 500-600 mg/L, approximately 
one third of which was from the site municipal water, with the balance from the soil.  
Significant decreases in sulfate were observed by day 60 (up to complete removal) in all 
treatments receiving corn syrup or lactate, especially in the media augmented tap waters. 
This indicated the presence of indigenous sulfate reducing bacteria, even though high 
concentrations of halomethanes were present.  
 Microcosm results are shown in Figure 4-5; each data point is the average of 
triplicate bottles.  The transformation rates observed are slower than what was reported 
for both cultures in MSM or RAMM.  For CT (Figure 4-5a, d, and g), transformation 
rates grouped in the following order, from fastest to slowest:  1) the biostimulation 
treatment with corn syrup + B12 in sulfate-amended media (FD’); all of the treatments 
with DHM-1 added; and the two SDC-9 treatments with amended media (FS’ nd FS); 2) 
the biostimulation treatment with corn syrup + B12 in buffered water (B); 3) the treatment 
with SDC-9 added to buffered water (B); and 4) the biostimulation treatments with corn 
syrup (no B12) in sulfate-amended media (FD’) and the one with corn syrup (no B12) in 
buffered water (B).  These results suggest that addition of B12 is essential for obtaining 
high rates of CT transformation, while bioaugmentation is not.  The presence of media 
rather than simply buffered tap water was beneficial.    
 Activity on CFC-11 was not initiated until removal of CT was nearly complete.  
However, significant levels of CFC-11 transformation were initially restricted to the two 
treatments receiving SDC-9 in media-amended water (FS’ and FS) (Figure 4-5h).  
Transformation of CFC-11 in the DHM-1 treatments with media-amended water (FD’ and 
 
 96
FD) also started after CT was removed, but at a slower rate (Figure 4-5e).  Addition of 
sulfide (0.5 mM on day 134) appears to have improved the rate of CFC-11 removal with 
DHM-1.  On day 162, the dissolved sulfide concentration was close to the detection limit, 
indicating that most of the sulfide was consumed.  Based on this result, a separate 
experiment was performed to measure the extent of sulfide consumption by reaction with 
the soil.  In serum bottles that received soil and municipal water, various initial amounts 
of sulfide were added and the amount remaining was measured after v rying periods of 
incubation.  As shown in Figure 4-6, soil from the industrial site exrt d a significant 
demand on sulfide.  To achieve a soluble sulfide level of 0.5 mM after 21 days of 
incubation required a dose of 0.85 mg S2-/g soil, equivalent to an initial sulfide dose of 8 
mM.  The importance of sulfide to maintaining high rates of CF transformation by DHM-
1 were reported in Chapter 3, although similar experiments have not yet been performed 
with CT and CFC-11.  In the treatments with sulfate-amended media (FD’, FS’ and B), 
additional sulfate was added, equimolar to the amount of sulfide added to the treatments 
with sulfide-amended water (FD and FS).   
 As with CT, the transformation rates observed through day 205 for CFC-11 in the 
microcosms are slower than in MSM and RAMM.  SDC-9 bioaugmented treatments were 
faster than those with DHM-1, consistent with its faster rate on CFC-11 observed in 
media (Table 4-2).  Unlike CT, high rates of CFC-11 biotransformation requires 
bioaugmentation.  Faster rates of CFC-11 transformation were also dependent on the 
presence of B12 and media-amended water.  Although transformation of CF was not 




 This study demonstrated the ability of the DHM-1 enrichment culure to 
biotransform high concentrations of mixtures of halomethanes. Furthermor , growth of 
DHM-1 on corn syrup was not affected by the presence of CF at concentrations up to 
4,000 mg/L, although transformation activity ceased at this level. It appears that tolerance 
to high concentrations of halogenated solvents is characteristic of Enterobacter species. 
For example, one strain closely related to Enterobacter agglomerans (strain MS-1) can 
grow in the presence of up to 10 mM tetrachloroethene (80). This characteristic of DHM-
1 may further broaden its applicability in source zone remediation for sites highly 
contaminated with CF.  For example, physical remediation strategies that target the 
nonaqueous phase liquid may precede biotic transformation of residual CF at 
concentrations up to 2,000 mg/L, which DHM-1 is capable of transforming.   
 In comparison to SDC-9, a commercially available bioaugmentation culture, 
DHM-1 is advantageous with respect to its higher rate of CF transformation.  However, 
SDC-9 exhibits a faster transformation rate with CFC-11.  The choice of culture for use 
in bioaugmentation must, therefore, take into account site specific conditions, e.g., the 
relative amounts of CFC-11 and CF.  With DHM-1, acclimation to CFC-11 may yield 
higher rates of transformation, as was observed when the culture was exposed to 
increasing levels of CF during successive transfers in MSM.   
 In the presence of B12, both bioaugmentation cultures transformed CT and CF to 
environmentally benign products. Over 50% of CT was transformed to CO2.  This is 
comparable to the recovery of CO2 from CT transformation by a DCM-grown culture (48) 
 
 98
and fructose-grown Acetobacterium woodii (47), also in the presence of B12.  As shown 
in Figure 1-1, conversion of CT to CO2 may occur via net hydrolysis of CT, hydrolysis of 
CS2 formed from CT via a substitutive reaction, or oxidation of CO generated through 
reductive hydrolysis of CT (47). Accumulation of CS2 from CT transformation is 
unwanted because of its toxicity. Formation of CS2 depends on a number of factors, 
including the presence of sulfide, coenzymes such as B12, or catalysts such as biotite or 
pyrite.  DHM-1 converted approximately one half as much CT to CS2 as SDC-9 (Table 4-
3), while the percentage formed by SDC-9 (10%) was similar to previous reports for a 
DCM-grown culture (i.e., 11%) (48) and fructose-grown Acetobacterium woodii (i.e., 13-
18%) (47).  The highest reported output of CS2 from CT is for a lactate-grown sulfate-
reducing enrichment culture (73%) (36), most likely related to a higher concentration of 
sulfide in the media.  
 For SDC-9 and DHM-1, CO was a major product from CF (55-67%) and, to a 
lesser extent, from CT (14-15%).  Reductive hydrolysis of CT to CO and net hydrolysis 
of CF to CO are shown in Figure 1-1.  B12 plays a significant role in favoring conversion 
of CT and CF to CO (12, 47).  Unlike CS2, CO is not a major concern from a toxicity 
standpoint.  Many anaerobes that use the acetyl-CoA pathway can grow on CO and 
others can oxidize CO to CO2 via CO dehydrogenase (66).  Both SDC-9 and DHM-1  
convert significant amounts of CT and CF to organic acids, which are also 
environmentally acceptable endpoints.   
 During the microcosm study reported in Chapter 2, the fermentative enrichment 
culture was not used until nearly all of the CT and CFC-11 were consumed, so its 
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principal function was to accelerate the rate of CF transformation.  During this 
microcosm study, the intent was to use DHM-1 from the outset, to accelerate the removal 
of CT and CFC-11 as well as CF.  Based on the results through day 205, bioaugmentation 
did not provide a significant benefit in terms of CT removal; i.e., biostimulation with 
corn syrup + B12 was equally fast in terms of CT transformation.  The CT transformation 
rates for both enrichment cultures in the microcosms were lower than what was achieved 
with DHM-1 in MSM and SDC-9 in RAMM (Table 4-2).  This suggested hat the soil 
exhibited some type of inhibitory influence on CT transformation.  Sulfide may be 
playing a key role.  The importance of sulfide in maintaining a high rate of CF 
transformation by DHM-1 was described in Chapter 3.  Although a similar evaluation has 
not yet been performed with CT, other studies have demonstrated the importance of 
sulfide in CT transformation (65).  The soil used in the microcosm study exerted a high 
demand for sulfide, so it appears unlikely that a residual levelwas available during CT 
transformation.  The soil demand for sulfide observed in this study was similar to a sandy 
soil used in another microcosm study (i.e., approximately 0.4-0.6 mg S2-/g soil) which 
investigated the use of calcium polysulfide to abiotically reduce hexavalent chromium 
(37).  To compensate for the soil sulfide demand, consideration should be given to 
increased addition of sulfide or sulfate, with the intent of fostering in situ sulfate 
reduction.  If a sufficient level of sulfide can be achieved, bioaugmentation to accelerate 
CT removal may then become worthwhile.  The higher concentration of sulfide and 
sulfate in the microcosms with MSM and RAMM-modified tap water w e not sufficient 
to overcome the sulfide demand of the soil.  It should also be noted that there is a risk 
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from overdosing with sulfide, in the form of increased conversion of CT and CFC-11 to 
CS2.  Getting the sulfide level correct in situ will be challenging.    
 Unlike the CT results, bioaugmentation of the microcosms has yielded higher 
transformation rates for CFC-11 in comparison to biostimulation with corn syrup + B12.  
Nevertheless, CFC-11 transformation rates are slower in the microcosms when compared 
to the results for DHM-1 in MSM and SDC-9 in RAMM (Table 4-2).  It is not yet clear if 
sulfide is a limiting factor for CFC-11 transformation.  Monitoring of sulfide is 
recommended so that once CFC-11 is consumed, sulfide levels close to 0.5 mM should 
be maintained to facilitate a high rate of CF biotransformation.     
 Although monitoring of the microcosms is still in progress, the information 
collected through day 205 from the experiments conducted in media indicates that both 
DHM-1 and SDC-9 are good candidates for bioaugmentation of sites contamina ed with 
high concentrations of halomethanes, especially CFC-11 and CF.  Since industrial sites 
that have high concentrations of CF may have a different mix of co-contaminants than the 
ones evaluated in this study, additional research is needed to evaluat the tolerance of 




4.6 Tables and figures 
    Table 4-1 Experimental design for the microcosm study 






As-is √ √    
Corn syrup √ √    
Corn syrup + B12 √ √    
Corn syrup + B12 + DHM-1 √ √ √   
Lactate + B12 + SDC-9 √   √ √ 
a B=buffered tap water, i.e., tap water + 4 g/L NaHCO3 + sulfate. 
b  FD'=DHM-1 media (i.e., modified MSM) prepared with tap water and sulfate 
replacing sulfide. 
c FD=DHM-1 media (i.e., modified MSM) prepared with tap water + sulfide. 
d  FS'=SDC-9 media (i.e., modified RAMM) prepared with tap water and sulfate 
replacing sulfide. 
e FS= SDC-9 media (i.e., modified RAMM) prepared with tap water + sulfide. 
f  One half the amount of phosphate was used versus the amounts found in MSM and 
RAMM, to reduce the possibility of precipitate formation during delivery into 
groundwater; the amount of NaHCO3 in RAMM was increased to 2.4 g/L, to reach 
neutral pH; the same amount of sulfide (0.5 mM) and yeast extract (50 mg/L) was 
added to the modified MSM and RAMM. 
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Table 4-2 Halomethane transformation rates (mg/L/d) 
 halomethane DHM-1 SDC-9 
Average CT 1.3±0.01a 0.82±0.06 
 CFC-11 0.54±0.01 0.67±0.12 
 CF 22±0.13 13±0.08 
Maximum CT 1.3±0.18b 1.1±0.04 
 CFC-11 1.1±0.05 2.3±0.30 
 CF 33±0.42 17±0.86 
a Data range for duplicate bottles. 






Table 4-3 Comparison of end product distribution of CT and CF transformation by DHM-1 and SDC-9 
 
Halomethane Culture % of [14C]CT or [14C]CF added 
CH4 CO CM DCM CS2 CF CT other CO2 NSR UA
a Loss 
CT DHM-1 0.1 14b 0.3 0 5.2 2.2 0 0.1 51 27 0 0 
 SDC-9 0.9 15 1.9 0 10 4.0 0.4 0.4 51 16 0 0 
CF DHM-1 0.5 67 0 0 0 0.9 0.2 0.8 2.7 15 0 13 
 SDC-9 0.4 55 1.7 0 0 0 0 0.3 9.9 16 0 17 
a UA=unaccounted for, i.e., percentage of remaining 14C that cannot be assigned to a particular compound or 
category. 








































Figure 4-1 Transformation of CT (a), CFC-11 (b) and CF (c) by DHM-1 in MSM 
with corn syrup and B12 added. LC=live control, MC+B12=media control with B12. 
Daughter products formed only in the DHM-1 + B12 treatments.  ↓=addition of corn 






























































































Figure 4-2 CF transformation by DHM-1 in MSM with corn syrup and B12 added 
(at t=0), at varying initial CF concentrations.  Arrows indicate addition of corn 























































Figure 4-3 Performance of DHM-1 in transforming mixtures of CT + CF (a), CFC-
11 + CF (b) and CT + CFC-11 (c) in MSM and B12 added (t=0).  Arrows indicate 




















































































































































































Figure 4-4 Behavior of a mixture of halomethanes in controls (a, b and c) and live 
bottles with DHM-1 and corn syrup + B12 in MSM (d). ↓ = addition of corn syrup;        
= addition of B12;   = reinoculation with DHM-1; WC=water controls, MC+B 12= 
media control with B12, and AC=autoclaved control with B12.  Error bars are the 

































































































































































Figure 4-5 Performance of biostimulation (a-c) and bioaugmentation with DHM-1 (d-f) and SDC-9 (g-i) in microcosms. 
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Figure 4-6 Sulfide demand of the soil used in the microcosms.  The dashed line at 0.5 
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 This study is the first to demonstrate that biostimulation and bioaugmentation are 
technically feasible remediation strategies for treatment of gr undwater contaminated 
with high concentrations of halomethanes, e.g., approximately 10 mg/L CT, 20-30 mg/L 
of CFC-11, and up to 2000 of mg/L of CF. Use of a catalytic amount of vitamin B12 is 
required to achieve reasonable transformation rates and direct the ransformation 
pathways towards environmentally benign products.  Corn syrup was the most effective 
primary substrate tested.  A principal outcome of this dissertation was the development of 
a fermentative enrichment culture, DHM-1, that is able to grow on corn syrup in the 
presence of high concentrations of CF and transform it, along with CT and CFC-11, at 
high rates to mainly CO, CO2, and organic acids.   
 The specific conclusions from this study are: 
1. Based on a microcosm study using soil and groundwater from an industral site in 
California contaminated with high concentrations of CT, CFC-11 and CF, corn 
syrup was a more effective primary substrate for biostimulation than lactate and 
emulsified vegetable oil.  Use of corn syrup shortened the time required to 
establish the low redox conditions needed for rapid anaerobic transformation of 
halomethanes and also yielded higher rates of halomethane transformation.   
2. The effectiveness of corn syrup was magnified considerably by addition of 
cyanocobalamin (vitamin B12) at a 1.3% molar ratio to the initial concentration of 
halomethanes.  Under this condition, transformation of approximately 500 mg/L 
CF, 26 mg/L CFC-11 and 10 mg/L CT was completed in microcosms in 
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approximately 1000 days. The predominant end products were CO, CO2 and NSR, 
demonstrating the importance of hydrolytic transformation processes rather than 
reductive dechlorination.    
3. Three bioaugmentation cultures were initially tested for their ab lity to increase 
the rates of halomethane transformation.  All of the cultures were d veloped with 
soil from an industrial site that was a focus of this research.  The lactate-grown 
SRB enrichment was initially beneficial for CT and CFC-11 transformation, but 
gradually lost its ability to respire lactate and also result d in an undesirably high 
level of CS2 as a product.  An ethanol-grown SRB enrichment was ineffective in 
enhancing the rate of CFC-11 or CF transformation.  A corn syrup-grown 
fermentative culture exhibited considerable promise in transforming residual 
levels of CFC-11 and high concentrations of CF; this culture became the focus of 
further development.   
4. Through repeated transfers in MSM (with corn syrup as the substrate and B12 
added) and acclimation to high concentrations of CF, the enrichment culture 
DHM-1 was developed.  A patent application covering DHM-1 has been filed.  
The culture is dominated by Pantoea (also known as Enterobacter) spp. and 
shows promise for use in bioaugmentation of sites contaminated with high 
concentrations of CF.  Distinctive characteristics of DHM-1 include a)  the ability 
to transform CF concentrations as high as 2000 mg/L to mainly CO, CO2, and 
organic acids at a maximum rate of 22 mg/L/d; b) the ability to grow on corn 
syrup in the presence of CF at concentrations at least as high as 4000 mg/L; and c) 
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the ability to alternate growth between under aerobic and fermentativ  conditions 
without losing the ability to anaerobically biotransform CF, making it relatively 
easy to handle for in situ applications (i.e., in comparison to obligate anaerobes).   
5. High rates of CF transformation by DHM-1 require the presence of 0.5 mM 
sulfide.  
6. Two Pantoea spp. were isolated from the DHM-1 enrichment culture: Strain 
DHM-1B, which grows comparatively fast and strain DHM-1T, which grows 
more slowly.  Both isolates grow fermentatively on corn syrup and in the presence 
of B12 are able to cometabolize 500 mg/L of CF at rates similar to the DHM-1 
enrichment culture.   
7. DHM-1 cometabolizes CT and CFC-11 in addition to CF.  When the 
halomethanes are present together (500 mg/L CF, 26 mg/L CFC-11 and 10 mg/L 
CT) in MSM, DHM-1 completes biotransformation of the mixture in less than 
four months, using corn syrup as its growth substrate and B12 as an amendment. 
8. In comparison to SDC-9, a commercially available bioaugmentation culture, 
DHM-1 transforms CF at a higher rate while SDC-9 transforms CFC-11 more 
quickly; they exhibit similar rates of transformation with CT.  Like DHM-1, SDC-
9 converts CT and CF mainly to CO2, CO and organic acids.   
9. DHM-1 and SDC-9 were evaluated in a second microcosm study with soil from 
the same industrial site.  For CT removal, biostimulation with corn sy up + B12 
was equally effective in comparison to bioaugmentation.  However, aft  CT was 
consumed, bioaugmented treatments significantly increased the rate of CFC-11 
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transformation.  SDC-9 exhibited a higher rate on CFC-11 than DHM-1, and 
addition of chemicals (in particular, sulfide) found in MSM and RAMM to tap 
water increased the rate of transformation over buffered tap water.      
10. Based on its ability to grow in the presence of CF at concentrations as high as 
4000 mg/L and to biotransform CF as concentrations as high as 2000 mg/L, 
DHM-1 shows promise for in situ remediation of source zones containing 
nonaqueous phase CF.  Nevertheless, site specific conditions, including the mix of 
contaminants present and their concentrations, will likely dictate what type of 




















A. Supplementary results of Chapter 2 
A.1  GC headspace results of individual microcosms in Chapter 2 
 
Nomenclature for the microcosms 
 The format used to name the microcosms is:  X – Y – Z - #, where 
• X =  
o CT if [14C]CT was added  
o CF if [14C]CF was added  
• Y =  
o H for the high concentration microcosm;  
o M for the medium concentration microcosm; 
o L for the low concentration microcosm; 
• Z =  
o AI for as-is conditions (i.e., no amendments except pH adjustment);  
o LA for biostimulation with lactate; 
o EM for biostimulation with emulsified vegetable oil; 
o CS for biostimulation with corn syrup; 
o CS-B12 for biostimulation with corn syrup + B12;  
o LA-SRB for bioaugmentation with enrichment cultures of SRB, although 
other cultures were also applied later   
o AC for autoclaved control; and 
• # = bottle number 1, 2, or 3; or ave (average of the triplicate, applicable only to AI 




































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 6-1 GC headspace results of all individual microcosms in the microcosm 
study in Chapter 2 
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A.2  Data used to determine first order rate constants 
 
H-SRB on CT

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 6-2 Data used to determine first order rate constants for the microcosm 
study in Chapter 2
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A.3  Sample data used to determine the first order transformation rate constants 
 
Principle 
The starting point of first order transformation of each parent contami ant (i.e., 
the end point of lag phase) in each individual microcosm, was determined as the point 
where a steady trend of removal initiated, not necessarily the maximum transformation 
phase initiated. However, for 1,1-DCE in bioaugmentation microcosms to which a 
chlororespiring culture was bioaugmented, results after bioaugmentation was used for 
determining the rate constants to emphasize the effectiveness of bioaugmentation. 
Examples 
Example 1: biostimulation microcosm CF-H-CS-B12-1 (determined first order reaction 
phase was highlighted in each figure) 
  









Figure 6-3  Sample data of first order transformation following a lag phase for a 
biostimulation microcosm with corn syrup plus B12 (CF-H-B12-1)
CT (CF-H-B12-1)
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Figure 6-4  Sample data of first order transformation following a lag phase for a 
bioaugmentation microcosm (CF-H-SRB-1) 
CFC-11 (CF-H-SRB-1)
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A.4  Percent removal of halogenated compounds in the microcosm study in Chapter 2     
Table 6-1 Percent removal of parent contaminants in the microcosm study in 
Chapter 2 
Treatment % removal a 
CT CFC-11 CF 1,1-DCE 
High WC (>800 days) 17.6 ± 13.9% 7.5 ± 9.0%  15.3 ± 11.4% 21.1 ± 8.0% 
AC 18.8 ± 9.0% 7.0 ± 2.7% 15.4 ± 7.2% 23.5 ± 3.2 % 
as-is 80.5 ± 14.8% 6.7 ± 5.3% 14.4 ± 11.2% 26.4 ± 9.8% 
lac 100.0 ± 0.0% 37.3 ± 5.0% 82.8 ± 4.9% 71.1 ± 9.2% 
EM 99.5 ± 0.2% 45.1 ± 7.4% 84.4 ± 4.9% 72.7 ± 7.4% 
CS 99.8 ± 0.3% 38.1 ± 5.7% 80.2 ± 5.0% 68.3 ± 6.4% 
CS + B12 99.5 ± 0.2% 92.6 ± 5.7% 99.9 ± 0.1% 68.1 ± 1.9% 
lac + B12 + bioaug 99.8 ± 0.2% 100.0 ± 0.0% 100.0 ± 0.0% 99.3 ± 0.5% 
Medium AC 13.7 ± 8.2% 2.8 ± 3.1% 3.5 ± 5.2% 18.1 ± 10.5% 
as-is 54.0 ± 11.1% 2.1 ± 2.6% 27.3 ± 27.7% 71.5 ± 10.2% 
lac 89.5 ± 16.8% 21.2 ± 7.2% 57.5 ± 17.5% 53.6 ± 8.8% 
EM 87.4 ± 7.9% 25.2 ± 7.7% 71.5 ± 17.4% 57.3 ± 8.6% 
CS 99.9 ± 0.1% 34.7 ± 9.9% 57.1 ± 10.4% 66.3 ± 8.9% 
CS + B12 99.9 ± 0.1% 98.2 ± 0.3% 99.9 ± 0.1% 90.5 ± 16.0% 
lac + B12 + bioaug 99.9 ± 0.1% 99.4 ± 0.1% 99.6 ± 0.4% 99.3 ± 1.3% 
Low AC 4.8 ± 5.7% 0.5 ± 1.1% 17.6 ± 20.4%  
as-is 26.3 ± 28.6% 4.4 ± 9.1% 14.5 ± 15.2%  
lac 51.2 ± 25.4% 11.0 ± 7.3% 4.0 ± 8.4%  
EM 64.9 ± 17.0% 12.8 ± 8.9% 7.2 ± 7.9%  
CS 88.2 ± 17.7% 21.0 ± 14.5% 0.0 ± 0.0%  
CS + B12 100.0 ± 0.0% 99.5 ± 0.4% 98.5 ± 1.1%  
lac + B12 + bioaug 100.0 ± 0.0% 100.0 ± 0.0% 98.3 ± 1.9%  







A.5  Characteristics of the soils used to prepare the microcosms.   
        Table 6-2 Characteristics of the soils used to prepare the microcosmsa 






Moisture (%) 24.4 19.7 22.7 
Organic Matter (%) 0.155 0.176 0.245 
Soil pH 5.6 3.9 3.7 
Buffer pH 7.8 7.7 7.5 
Carbon (%) 0.075 0.043 0.041 
Nitrogen (%) 0.021 0.026 0.025 
C/N Ratio 3.6 1.7 1.6 
Nitrate-N (ppm) 2 3 4 
Phosphorus (ppm)b 256 169 236 
Potassium (ppm)b 31 30 32 
Calcium (ppm)b 654 1,954 1,265 
Magnesium (ppm)b 113 28 105 
Sodium (ppm)b 355 36 62 
Sulfur (ppm)b 33 1,252 815 
Boron (ppm)b 0.1 0 0.1 
Zinc (ppm)b 1.2 0.4 0.6 
Manganese (ppm)b 20 4 4 
Copper (ppm)b 0.4 0.2 0.3 
Iron (ppm) 35 165 87 
Aluminum (ppm) 347 211 466 
Bulk Density (kg/m3) 1,818 2,000 1,905 
a High, medium and low refer to the halomethane concentrations; abbreviations in 
parentheses refer to the soil core used.  
b Results converted from lb/acre to ppm by dividing by 2 (according to the analysis 





A.6  Characteristics of the precipitates formed by pH adjustment 
Table 6-3 Composition of the precipitates (%) 




N 0.00 0.00 
P 0.06 0.04 
K 0.03 0.02 
Ca 5.41 9.27 
Mg 0.08 0.56 
S 1.28 1.09 
Cl 0.00 0.00 
Zn 0.0459 0.0346 
Cu 0.0023 0.0048 
Mn 0.0521 0.152 
Fe 15.6 5.51 
Na 0.764 1.27 
B 0.00 0.00 
Al 11.0 11.6 
nitrate 0.00 0.00 


























A.7  Organic acids analysis for the microcosms in Chapter 2 at the end of incubation 
Table 6-4 Organic acids analysis for the microcosms in Chapter 2 at the end of 
incubation 
Treatment % of COD added 
Total  lactate  Formate  Acetate  Propionate  Butyrate  
CF-L- lac + B12 + bioaug  85.7% 0.0% 0.0% 44.3% 41.4% 0.0% 
CS + B12 21.9% 0.0% 2.8% 19.1% 0.0% 0.0% 
CS 34.8% 0.0% 1.0% 26.4% 4.5% 2.9% 
emul oil  3.2% 2.3% 0.1% 0.6% 0.1% 0.0% 
lactate  86.5% 86.5% 0.0% 0.0% 0.0% 0.0% 
CT-L- lac + B12 + bioaug  90.4% 0.0% 0.0% 47.6% 42.8% 0.0% 
CS + B12 60.1% 0.0% 0.1% 50.9% 4.6% 4.5% 
CS 41.4% 0.5% 1.4% 34.6% 4.9% 0.0% 
emul oil  0.8% 0.0% 0.0% 0.8% 0.0% 0.0% 
lactate  88.6% 80.0% 0.0% 8.7% 0.0% 0.0% 
CF-M- lac + B12 + bioaug  63.9% 0.0% 0.0% 39.9% 23.9% 0.0% 
CS + B12 56.4% 0.0% 0.0% 56.4% 0.0% 0.0% 
CS 51.8% 0.0% 0.1% 46.5% 5.2% 0.0% 
emul oil  1.4% 0.7% 0.0% 0.1% 0.5% 0.0% 
lactate  60.0% 2.7% 0.0% 49.7% 7.6% 0.0% 
CT-M- lac + B12 + bioaug  65.1% 0.0% 0.0% 41.4% 23.7% 0.0% 
CS + B12 47.1% 0.0% 0.0% 45.5% 1.6% 0.0% 
CS 49.3% 0.0% 0.1% 46.0% 3.2% 0.0% 
emul oil  1.6% 1.3% 0.1% 0.2% 0.0% 0.0% 
lactate  84.2% 77.9% 0.0% 4.4% 1.8% 0.0% 
CF-H- lac + B12 + bioaug  68.9% 0.0% 0.0% 31.0% 37.1% 0.8% 
CS + B12 46.3% 2.9% 6.1% 21.8% 14.7% 0.7% 
CS 57.2% 1.5% 5.0% 27.4% 2.2% 21.2% 
emul oil  1.0% 0.3% 0.0% 0.8% 0.0% 0.0% 
lactate  84.0% 41.0% 0.0% 10.7% 32.3% 0.0% 
CT-H- lac + B12 + bioaug  67.9% 0.0% 0.0% 24.4% 41.6% 1.9% 
CS + B12 50.5% 14.0% 4.6% 19.6% 8.4% 3.9% 
CS 50.0% 0.7% 5.3% 28.6% 5.1% 10.3% 
emul oil  3.8% 0.5% 0.0% 1.7% 1.6% 0.0% 
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Figure 6-6 Fate of lactate in the high (a) and medium (b) concentration 





B. Supplementary data for Chapter 3 





















DHM-1 + CS + B12 + CF




Figure 6-7 Comparison of growth pattern of DHM-1 with and without CF
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Figure 6-8 Effect of sulfide (0.5 mM) on CF transformation by DHM-1 in MSM 
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B.3 CF-transformation ability of DHM-1 after 24 h exposure to air and then returning 






















Figure 6-9 CF-transformation ability of DHM-1 after 24 h exposure to air and then 























BLAST failed due to 


























































bacterium WN042 gene 

















































































Figure 6-10 Growth curves of the two DHM-1 isolates, i.e., DHM-1 B and DHM-1T, 
in MSM + corn syrup (960 mg COD/L) and B12 (3% mole ratio), with and without 
CF (500 mg/L) 
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C. Supplementary data for Chapter 4 










































Figure 6-11 Media controls (without B12) for CT, CFC-11 and CF  
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Figure 6-12 Transformation of individual halomethane by SDC-9 in RAMM, 
LC=live control, MC+B 12=media control with B12. Daughter products formed only 



























































D.1  PCR protocol using Eppendorf Master Mix 
Sequence                Reagent                              Amount (µl) 
       1             Autoclaved DDI water                          26/23                             28 (for NC) 
       2             Forward Primer                                        1 
       2             Reverse Primer                                         1 
       3             Master Mix                                              20 
       4             Template DNA                                        2/5 
Note:  
1. always include a negative control to show any contamination. Working in a clean 
hood is recommended. 
2. Recommended template amount: 30-50 ng [from Dr. Kurtz]; 25-30 cycles [PCR 
Analysis, Chapter 16, Basic Techniques In Molecular Biology, Stefan Surzycki, 
1999] 
 
Votex, centrifuge @ 10K rpm for 0.5 min. Then ready for PCR using program TB-PCR1. 
 
After PCR, run agarose gel at 80v for 1.5 hr.   
1. Load: 1 µl dye + 3 µl PCR DNA sample; same amount for ladder. 
2. Stain DNA on the gel by immersing in an ethidium bromide solution (about 5 µl in 
200 mL DDI water) in a plastic tray, shaking gently for about 10 min. 
3. Pour the ethidium bromide solution and change to DDI water for rinsing. 
4. Watch the gel under UV by BIO-RAD universal hood II and get a picture for the 
bands. 
 
Gel Preparation  
Measure 70 mL 1X SB buffer into a conical flask, add 1.05g agarose into it (i.e. 1.5%), 
weigh it; put into microwave oven, carefully heat it until boiling, stop and check whether 
it’s become a clear solution, which may take about 1 min. Then slowly pour into gel 
chamber to avoid generating air bubble, put on the well maker, then cool ab ut half a 
hour to solidify. Pack it with clean wrap and store in fridge.  
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D.2   DGGE protocol  
1) Prepare 6% acrylamide solutions 
 0% 10% 50% 100% 
40% acrylamid/bis (37.5:1) 15 mL 15 mL 15 mL 15 mL 
20X SB 2 mL 2 mL 2 mL 2 mL 
Deionized formamide  4 20 mL 40 mL 
Urea  4.2 21 g 42 g 
DDI water To 100 mL To 100 mL To 100 mL To 100 mL 
a) Prepare the solutions according to the formulas in the table above. 
i) Be sure to work in the hood as much as possible. Acrylimde is a neurotoxic. 
Avoid breathing the vapors. 
ii)  To prepare 100% solution, use a 150 or 250 conical flask (make a mark for 
100 mL) first. After adding the first 4 items (total volume will be less than 100 
mL), add a few mL DDI, stir and slightly heat for around 15 min, will 
completely dissolve. Then transfer to a 100 mL vol. flask topping to 100 mL 
with DDI. 
b) Degas the solutions for 30 minutes 
i) Place the solution in a 125 mL Erlenmeyer flask with a port 
ii)  Place a stir bar in the flask and place a cork (stopper) in the flask 
iii)  Place the flask on a stir plate, set to gently stir the solution (you don’t want a 
vortex to form) 
iv) Attach a vacuum hose to the port and apply vacuum pressure 
c) Store the solutions in amber bottles in the fridge for up to 1 month 
2) Glass Plate Preparation 
a) ____ Rinse 5 X with DDI water 
b) ____ Air dry or use a lint-free tissue 
c) ____ Wipe the inner surface of the plates with 95% ethanol and dry with lint-
free tissue 
d) ____ Apply gel-repel (CBS Scientific) to one side of the back glass plate (this 
will be the inside of the sandwich next to the gel) 
3) Cast the Gel 
a) ____ Start with the back plate (the one with the rounded corners) 
b) ____ Apply the gasket starting at the bottom 
i) Make sure the rounded side of the gasket is on the inside (the side you applied 
gel repel to) and that the flat side is on the outside 
ii)  Make sure the notches on the gasket align with the rounded corners of the 
glass plate 
iii)  Work the gasket down around both sides 
c) ____ Place the gasketed plate on the lab bench with the tubing side up, and 
extend the bottom of the plate over the edge of the bench, approximately 
¾ of an inch. 
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d) ____ Place the spacers along side the inside edges of the gasket 
i) Be sure the rounded scorner end of each spacer is facing the outside bottom of 
the plate, following the radius of the glass. 
e) ____ Place the notched plate on top of the bottom assembly, starting from the 
bottom edge and gently easing the plate down 
f) ____ Verify the gasket is smooth around the edges 
g) ____ Clamp along the bottom 
i) Make sure the glass rests against the body of both clamps 
h) ____ Lift the assembly and stand it on the base of the clamps 
i) ____ Clamp the sides of the assembly with two clamps per side 
i) Be sure the gasket is aligned between the plates, forming a seal 
j) ____ Blow the assembly with air, empty remained water inside the fitting and 
tubing. 
k) ____    Place the assembly upright on the lab bench near the stir plate to be used 
for the gradient caster 
l) ____ Tape the needle of the gradient caster to the top of the assembly, with the 
needle between the plates and centered horizontally 
m) ____ Make sure both valves on the gradient maker are closed 
n) ____ Place a small Teflon coated stir bar in cylinder 2 (C-2) 
o) ____ Make Solution A & Solution B (add TEMED and 10% APS to the 
acrylamide solutions) 
(Note: Prepare pipets with tips on, beaker, chemicals at hand to expedite this step.) 
i) Solution A is the lower % denaturant & Solution B is the higher %  
denaturant 
ii)  Filter the acrylamide solutions (pour ~15 mL into a third beaker, 
suck 15 mL using a 20 mL syringe with a 18G1 needle) 
iii)  Avoid introducing gas into the acrylamide solutions while filtering 
through a 0.45 um filter into a beaker, one beaker for each solution 
iv) Add 15 µL TEMED 
v) Add 150 µL 10% APS 
(Note: No need to mix them, handle step p immediately.) 
p) ____ Pour solution B (the denaturing acrylamide) into the cylinder (C-2) nearest 
the outlet 
q) ____ Open valve 1 (V-1) and allow approximately 1 mL of solution B to pass 
into C-1 
r) ____ Close valve 1 (V-1) 
s) ____ Use a pipette to transfer all of the solution from C-1 back to C-2 
t) ____ Open valve 2 (V-2) and allow some of solution be to flow into the glass 
plate assembly 
(Note: steps q-t are optional, can skip them. Handle steps p-w in a minute after step o!) 
u) ____ Add solution A to chamber C-1 
v) ____ Turn on the stir plate 
w) ____ Open valve 1 (V-1) and then valve 2 (V-2) 
x) ____     Tilt the assemble in case there is air bubble i  
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y) ____ Once all of the acyrlamide solutions have fed into the glass plate assembly, 
insert the 16-well rectangular tooth comb 
z) ____ If the gel volume is not enough to fill the sandwich (to fill in around the 
comb), top-off with 0% denaturing acrylamide 





1. Take off the comb 
2. Remove the clamps, put the assembly on the stand with the back plate facing outside, 
take the gasket out at the bottom 
3. Fix the assembly and the stand using 4 bigger clamps 
4. Transfer the assembly into the water bath, fill the top trough with water, remove air 
bubbles at the bottom using a syringe w/ a bent needle 
5. Connect the influent tubing, control its flow by a adjustable clip to get continue 
dropping at the outlet and a suitable water level in the trough 
6. When temperature reaches 60 oC, confirm there is no air bubble at the bottom, then 
load samples (around 5-15 µL depending on concentration of the PCR products; 
recommend 500 ng by H Schafer and G Muyzer in chapter 22, Method in 
Microbiology v30, v12, (2001)).  
7. Connect the black cord, turn on 140, run 2.5 hrs 




1. Take the assembly out, remove the clamps and gasket 
2. Put the gel with plates together in a shallow DDI water bath with the back plte 
facing up, and then remove it 
3. Transfer the gel and front plate into staining bath (~200 mL), stain 10-20 min, then 
destain in DDI water bath for 5-10 min 






D.3  Preparation of the medium for DHM-1 
Table 6-5 Minimal salts medium for DHM-1 
Constituent Concentration 
NH4Cl 0.3 g/L 
KCl 0.3 g/L 
CaCl2·2H2O 0.15 g/L 
MgCl2·6H2O 0.4 g/L 
K2HPO4 0.41 g/L 
NaHCO3 4.0 g/L 
Resazurin 0.001 g/L 
Yeast extract 0.05 g/L 
Na2S·9H2O
a 0.12 g/L 
Selenite solutionb 1 mL/L 
Ferrous solutionc 1 mL/L 
Trace metal solutiond 1 mL/L 
a All compounds except sodium sulfide were added into autoclaved distille deionized 
water, purged with 30% CO2 and 70% N2 for a few minutes until complete dissolution of 
mineral salts, and then placed in an anaerobic chamber where 0.12 g/L (i.e., 0.5 mM) 
sodium sulfide was added, media turned clear (indicating Eh dropped below -110 mV) in 
hours. pH was approximately 7.5. 
b 3.0 mg Na2SeO3·5H2O,  5.0 mg/L NaHCO3. 
c 3.0 mg FeCl2·4H2O, 5.0 mg/L NaHCO3. 
d FeCl2·4H2O (1.5 g/L), CoCl2·6H2O (0.190 g/L), MnCl2·4H2O (0.1 g/L), ZnCl2 (0.07 
g/L), H3BO4 (0.006 g/L), Na2MoO4·2H2O (0.036 g/L), NiCl2·6H2O (0.024 g/L), and 
CuCl2·2H2O (0.002 g/L).  
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D.4  Preparation of RAMM for SDC-9 
 (Revised Anaerobic Minimal Media, modified from Shelton and Tiedje (81)) 
A. Buffer Solution (100x)  Dissolve in 1 L dH2O: 
KH2PO4  27.0 g 
K2HPO4  35.0 g 
B. Mineral Salts Solution (100x)  Dissolve in 1 L dH20: 
 NH4Cl   53.0 g 
 CaCl2-2H2O   7.5 g 
 MgCl2-6H2O  10.0 g 
 FeCl2-4H2O   2.0 g 
C. Trace Metals (1000x)  Dissolve in 1 L dH2O: 
 MnCl2-4H2O  5.00 g 
 H3BO3   0.05 g 
 ZnCl2   0.05 g 
 CuCl2   0.03 g 
 NaMoO4-2H2O 0.01 g 
 CoCl2-6H2O  0.50 g 
 NiCl2-6H2O  0.05 g 
 Na2SeO3  0.05 g 
 Add ~1 mL of 38% HCl to keep metals in suspension  
D. Resazurin Solution (10,000x)  Dissolve 0.1 g Resazurin in 10 mL dH2O. 
1x Media: 
1) Mix a [1X] solution of A, B, C, and D in DDI water 
2) Autoclave, then bring to boil (or almost boil) while sparging with high purity N2 
3) Let cool while sparging 
4) Add 1.2 g NaHCO3 per liter of media, and 0.5 g/L yeast extract, then cap the bottle 
5) Transfer into anaerobic chamber where 0.12 g/L Na2S·9H2O
 was added, cap the 
bottle, Media should turn clear in few hours, then may turn dark overnight. Store the 
media inside anaerobic chamber.  
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D.5   Transferring DHM-1 
1) 5% transferred (i.e., add ~ 5 mL culture into ~ 93 mL fresh media (MSM)) 
2)  Add ~ 960 mg COD/L corn syrup (by ~0.266 mL 360 mg COD/mL stock a) and 
1.84 mL B12 stock (1% weight/volume) 
3)  Purge the headspace with 30% CO2/70% N2 for 1 min 
4)  Spike 500 mg/l CF (by weight) by adding 36 µL neat CF  
5)  Equilibrate on shaker for 2-3 days before initial GC headspace analysis  
a assuming corn syrup is 100% composed of glucose  
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D.6  Dissolved sulfide measurement  
 
Follow the methylene blue colorimetric assay in Standard Methods, except using 1/10 of 
the volumes of samples and reagents specified 
1) Take 0.75 mL of each standard solution into a 2.0 mL microcentrifuge tube, using 
a replicate of one or two standards as tube B (as blank for spectrophotometer 
analysis)  
2) Add 50 µL amine-H2SO4 reagent, 15 µL FeCl3 solution (tube A), while 50 µL 
1+1 H2SO4, 15 µL FeCl3 solution (tube B) 
3) Mix once by inverting gently, wait 3-5 min, develop blue color 
4) Add 0.16 mL (NH4)2PO4, wait 3-15 min, produce white precipitate (suggest -  
centrifuge to settle the precipitate) 
5) Measure absorption of the liquid phase samples at 664 nm using Beckman DU 
640 spectrophotometer with 1 mL cuvette 
 
 192
E. Supplementary experimental results 
E.1  Amount of corn syrup added in each transfer of DHM-1 to transform 500 mg/L CF 
Transfer Corn syrup added (# of dose, 



































































































































































Figure 6-13 Test of ability of a culture that grows anaerobically on DCM to use 
chlorofluoromethane. Where, DCM-A: CH2ClF was added together with DCM after 
growth on DCM was established; DCM-B: only CH2ClF was added after growth on 





























































































E.3  Response factors of GC 
 
Table 6-6 Response factors of GC for 160 mL serum bottles with 50 mL liquid phase 
and 99 mL headspace  
Compound GC RT RF Conversion Factor Date 
(min) (µmol/bottle/ 
Peak Area) 
R2 (µmol/btl to mg/L)  
Methane 0.50 3.981E-06 0.9903 0.000136 7/27/2005 
Chloromethane 1.22 1.284E-05 0.9961 0.6224 6/25/2005 
CH2ClF 1.54 3.086E-05 0.9990 0.8689 6/25/2005 
CHCl2F 4.2 2.647E-05 0.9866 1.4406 6/25/2005 
DCM 4.6 3.136E-05 0.9975 1.4649 7/27/2005 
CS2 5.4 7.490E-04 0.9949 0.5905 7/27/2005 
CFC-11 5.68 1.587E-05 0.9965 0.3223 7/31/2008 
CF 7.16 2.469E-05 0.9991 1.8881 7/27/2005 
CT 8.6 8.780E-06 0.9989 0.9564 7/27/2005 
 
Table 6-7 Response factors of GC for 160 mL serum bottles with 100 mL liquid 
phase and 60 mL headspace 
Compounds RF Conversion Factor Date 
(µmol/bottle/ 
Peak Area) 
(µmol/btl to mg/L)  
Chloromethane 1.221E-05 0.4248 3/6/2007 
CHCl2F 3.139E-05
a 0.9109  
CH2ClF 5.703E-05
a 0.5830  
DCM 5.315E-05 0.8101 1/11/2008 
CS2 7.223E-04 0.5150 1/11/2008 
CFC-11 1.366E-05 0.4188 6/4/2007 
CF 4.571E-05 1.1052 1/11/2008 
CT 9.250E-06 0.9202 1/11/2008 
 
a Estimated from the RFs from Table 6-6 using the equation: Cg = M/(Vg+VL/Hc) (i.e., 
using the equation to get the RFs for Cg/peak area, then convert Cg to M using 
M=Cg(Vg+VL/Hc))  because neat compounds of these two HCFCs were no longer 
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